ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000394.1|Naphthyridinomycin_1 # 1 # 2493 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.710	BGC0000394.1|Naphthyridinomycin_1 	1	2493	+	Loose	1050	55.8398	lmrC	37.27	3002881	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGACGGAAAGCACGCGCACCTCGGAGACCATCGAGGTGGTGGGAGCACGGACCAACAACCTCCGCGACGTCACCGTGCGGATCCCCAAGGGACGGGTGGTGGCCTTCACCGGCGTCAGCGGCAGCGGCAAGACCTCCTTAGCCATCGACACCTTGCACAACGAGGCCCAACTCCGTTATCTGGAAGGGCTCTCGCCGTTCGTCCGGCAGTACATCACCCAGCGCAACCGCCCCAAGGTGGACCGCGTCCTCGGCCTGGGCGCCACCCTCGCCGTCGACCAGCGCCGGCTCAACCGCAACCCGCGCTCCACCGTCGCGACCATCACCGGCATCGACGGCCACCTCGGACTGCTCTACTCCCGGCTGCCCGGCATCGGCCCGGGAACGCCTCCCGGTGACGGCCCTCTCAGCTCCGCCCACTTCGACCGGCACACCCCGGAGGGGAGCTGCTCCGCCTGCCACGGCGTCGGCGGTCTCTGGCAGGCGCGGGAGGAACTCGTCATCACACGGCCGGAGTTGCCCCTCTTCGAGGGAGCCTCCCCCTGGTACGCGAAGTGGCGTTCCGCCGAACACGCCTTCATCCCCGCACTGGCCGAGAAGCGCGGCGTGGACCTCGCCCTGCCCTGGCAGTCGCTGCCCGAGCGCTTCCGGCACGAGGTGCTGTACGGCACGGGTGACGAGAAGATCGAAGCCACCGTCGACATGCCGAACAAGAACGAGACCTCCTCCTGGACGTACACCTCCAGCGAGCCGCTGCGCGGAGCGCTCGCCGAGGTGGAGCGGGTCTTCGCGAACGCGGCGACCCCCAGCGCGAAAGAGCGCTACCTGCCGTACATGCGCAAGATGCCCTGCACCACCTGCGGGGGCACCGGCTACGACGAGATCGCCCGGTCGGTACGGCTGGGCGGACTCGCCTACCCGGAACTGCTGGAGGCCGACGTCCGCGAGGTACGCGCCTGGGGCGACCGGGTCACCTCCGGCCTCGACACCGCACAGCGCGCGGTCGGCGAACCCCTCCTGCAGGATCTCGCCCGCAGACTCCGGGTGCTGGACCGCCTCGGCCTTGCCCACGTCCAACTGTCCCGCAGCGCGGCCACCCTGTCCGGCGGCGAACTCCAGCGCACCCGGCTCGCCGCCCAGCTCAGCACCGAACTCAGCGACATCATCTTCGTGCTCGACGAACCGGGCACCGGCCTCCACCCCGCCGACAAGGCCCATCTGCTGGACATGGCACGGGAGCTGCGCGCCGCCGGGAACACCGTGCTGCTGGTCGAGCACGACCCGGAACTCATCGCCCGCGCCGACTGGGTGATCGACATGGGACCGGGCGCCGGACGGCTGGGCGGCGAGGTGCTCGTCTCCGGCACCCCCGCCGACGTCGCAGGGCATCCCCGCTCACTCACCGGCCACTACCTCGCCGGGAAGGGACCGCGGCTGCGCCGTACCCGTCGGCCGGTCGGGGAGGGCACCGCCTGGGTGGAGCTCCACGGGCTGTCCGCGCACAACGTGACAGCGGACCTGGTCCGCTTCCCCGTGGGCCGGCTGACCTGCCTGACCGGGGTCAGCGGCAGTGGCAAGAGCAGCCTCCTCGGCGCCCTCGGTGCCGGCAGCGAGGCGGCTCTGACCGGAACGGCGACCGACACCGTCCGCCGGGTCACCGGTGCCGAGACCTTCGGCTGGGTCGCCGTGGTCGACCAGGAGCCGATCGGCCGGACACCCCGGTCCAACCCCGCCACCTACAGCAAAGCGTTCGACATCGTCCGCAAGCTGTTCGCGGAGACCGACGAGGCACGCAAGCGCGGCATCAAGGCCTCCTGGTTCTCCTTCAACGCGGCCAACGGCGGACGCTGCGAGGTCTGCACCGGGTACGGCCGCAAACTGGTCGACATGCACTTCCTGCCGGACGTGTGGGTGGTCTGCGACGCCTGCGAGGGACGCCGCTACACACCGGAGGCCCTGGAGATCACCTACCAGGGACTGACCATCGACGGGGTGCTGGAGCTGACCGTCGCCGAGGCCGTCGAACGCCTCACGGAGAACCGTCAGCTGGCGGAGGCGCTGAAGGCCATGGACCGGGTCGGCCTCGGCTATCTCCAACTCGGCCAGAACGCCACGGAACTCTCCGGAGGCGAGGCGCAGCGCCTCAAGCTCGCGTCGGCGATCCAGCGCGGTTCCGCGGGACGCAAGGCCGGACTGGTCGTGCTCGACGAACCAGTCTCGGGCCTGCACCCCTCCGACATCCAGCGCATGGTGGACGCCTTCGACCTGCTCCTGGACTCGGGCAACACGGTGGTCGTCGCCGAGCACGACATCCCCGTCGCGGCCTCCGCGGACTGGGTGATCGACCTCGGCCCCGGCGCCGGACCGGACGGAGGCGCCGTCGTGGCGGCGGGCGTCCCTGACCAGGTCGCCGAGGCCCACACCCCGACCGCGGGCTATTTCCGCCGGTACATGGCGGGCCTGCCGCTGCTGGACGGGCACGGCGACCACTGA	MTESTRTSETIEVVGARTNNLRDVTVRIPKGRVVAFTGVSGSGKTSLAIDTLHNEAQLRYLEGLSPFVRQYITQRNRPKVDRVLGLGATLAVDQRRLNRNPRSTVATITGIDGHLGLLYSRLPGIGPGTPPGDGPLSSAHFDRHTPEGSCSACHGVGGLWQAREELVITRPELPLFEGASPWYAKWRSAEHAFIPALAEKRGVDLALPWQSLPERFRHEVLYGTGDEKIEATVDMPNKNETSSWTYTSSEPLRGALAEVERVFANAATPSAKERYLPYMRKMPCTTCGGTGYDEIARSVRLGGLAYPELLEADVREVRAWGDRVTSGLDTAQRAVGEPLLQDLARRLRVLDRLGLAHVQLSRSAATLSGGELQRTRLAAQLSTELSDIIFVLDEPGTGLHPADKAHLLDMARELRAAGNTVLLVEHDPELIARADWVIDMGPGAGRLGGEVLVSGTPADVAGHPRSLTGHYLAGKGPRLRRTRRPVGEGTAWVELHGLSAHNVTADLVRFPVGRLTCLTGVSGSGKSSLLGALGAGSEAALTGTATDTVRRVTGAETFGWVAVVDQEPIGRTPRSNPATYSKAFDIVRKLFAETDEARKRGIKASWFSFNAANGGRCEVCTGYGRKLVDMHFLPDVWVVCDACEGRRYTPEALEITYQGLTIDGVLELTVAEAVERLTENRQLAEALKAMDRVGLGYLQLGQNATELSGGEAQRLKLASAIQRGSAGRKAGLVVLDEPVSGLHPSDIQRMVDAFDLLLDSGNTVVVAEHDIPVAASADWVIDLGPGAGPDGGAVVAAGVPDQVAEAHTPTAGYFRRYMAGLPLLDGHGDH	MADASIVCTNLSFSWPDETPVFDGLSFALGAGRCGLVGPNGAGKSTLLRLAVGELTPTAGSITAQGHVGYLPQSLPLIDGTVDEALEIASIRAALHAIESGDVDEAHFTTVGDHWDIEERTTIVLDRLGLGDVSLDRPLRSLSGGQVLAIGLAAQLLKRPDVLILDEPTNNLDLAARQRLYQVVEEWKGALLVVSHDRELLDRVDTIAELQASELRLYGGNFTAYTEAVELEQENVQRAVRGAEQELRRHKREAQAAQERAQRRASNAKRNKASSGVPRIHAGALQRQAQESAGRAASVHQDRVSQAKAKLDEASQGMREEARLAITLPQTSVPAGRTVLTCHEANVRYGERTLFTGSGVDLGIRGPERIALLGPNGSGKSTLLKLIAGELEPSSGTVTAPTDRVSYLSQRLDLLDLDASVLDNLRRFAPHLQDGEVRYRLAQFLFRGDRVHRTAGWLSGGERLRATLACVLSTDPAPQLLLLDEPTNNLDLNSAAQLENALNAFQGAFVVVSHDQAFLRAIGVSRWLRLADGTLEEIAEADDAWPHRDK	150.91	gnl|BL_ORD_ID|900|hsp_num:0	974			369	684	lincomycin; clindamycin; celesticetin
BGC0000394.1|Naphthyridinomycin_2 # 2534 # 3799 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=4bp;gc_cont=0.750	BGC0000394.1|Naphthyridinomycin_2 	2534	3799	-	Loose	800	27.7202	PDC-384	30.99	3005283	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	GTGTCCTCCGCGTTGTTCGTCGCGCTCGTGCTGCCGGTCCTGGCCGGCGCCCACTTCTACGTGTGGTGGCGGATGGTCCGCGCCACGACGTCCCCCGGTTCGTGGTGGCGCCGGGCCGGTACGGCCCTGATCGTTCTGCTGGCGCTGCTGCTGGTGGCCGCGCCGCCCGGGGAGCGCGCGCTGCCCGCACCACTGGCCACCGCGGTCGGCTGGCCCGGCTTCACCTGGATGGCGGGGCTCCTCTACCTGACGCTGGCGCTGCTGGTGGGGGAGGCGGTCCGCCCCTTGCTGATGCGGGTCCGGCGGCGGCGCTCCGTCGGCGACACGGCGCCCGCGGCCCGGAGCACGGCGTCCGAGGGCGATGGGGAGCACCCGTACGGTACGGGCCCCGCGTCAGGCCCGGACGTCCCGGCGCCGGCCTCGGCCGACGAGTTCCCGGCGTCCCGTCGCATGTTCGTGAGCCGGGTCGTCGCCGTCGCCGCCGGGACCGCCGCCACCGCCGCCGTGGGGTACGGCGCGTACACCGCGCTGGGGCCGCCCCGCGTCAGGCACCTCGTCGTGCCCCTCGCCCGGCTCGGCCCGCAGGCCCACGGCTTCCGGATCGCGCTGATCAGCGACATCCATCTGAACGTCCTGGTGGGGCGTTCCCGCACGCGGCAGTTGGTGGACCTCCTCAACGGCACCGAGCCGGACCTGGTGGCGCTCGTCGGTGATCTGGTGGAGGACGCCGACGTGGCTGTCCAGGGGCGGGCCGCCGAACCGCTCGCGGACCTGCGGGCGCCGCACGGCGCGTACTACGTCACCGGGAACCACGAGTTCTACTCGGGCGCCGAGCAGTGGGTCCGCTTCGTGAGCGGGCTCGGACTGCGTCCCTTGCGCAACGAGCGGGTCGCCCTGCCGGGCTTCGACCTGGCCGGGGTCGAGGACGCGAGCGGTGTCGACCATGACGACGACCCCGACTACGAGGCCGCGCTGGGCGGACGTGACCGGGACCGGGCCGTCGTCCTCCTCGCCCACCAGCCCGCTCAGGTCACGGAGGCCGCCCGGTACGGGGTGGACCTCCAGTTGTCCGGGCACACCCATGGCGGCCAGCTCTGGCCCTTCACCCGTCTCGCGTCCCTGGTCGAGCCGAACGTCGCCGGGCTGAGCCGGTACCGGGACACCCTGCTCTACGTGAGCCGGGGCACCGGCTTCTGGGGGCCGCCCGTCCGCCTGGACGCCGACCCGGACATCACCGTCGTGGAACTGGCGTCGCCCCGCGCCTGA	MSSALFVALVLPVLAGAHFYVWWRMVRATTSPGSWWRRAGTALIVLLALLLVAAPPGERALPAPLATAVGWPGFTWMAGLLYLTLALLVGEAVRPLLMRVRRRRSVGDTAPAARSTASEGDGEHPYGTGPASGPDVPAPASADEFPASRRMFVSRVVAVAAGTAATAAVGYGAYTALGPPRVRHLVVPLARLGPQAHGFRIALISDIHLNVLVGRSRTRQLVDLLNGTEPDLVALVGDLVEDADVAVQGRAAEPLADLRAPHGAYYVTGNHEFYSGAEQWVRFVSGLGLRPLRNERVALPGFDLAGVEDASGVDHDDDPDYEAALGGRDRDRAVVLLAHQPAQVTEAARYGVDLQLSGHTHGGQLWPFTRLASLVEPNVAGLSRYRDTLLYVSRGTGFWGPPVRLDADPDITVVELASPRA	MRDTRFPCLCGIAASTLLFAATPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASKHWPALQGSRFDDISLLDLATYTAGGLPLQFPDSVQKDRAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMAPQPHRIARLPAPQALEGQRLLNKTGSTSGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR	106.05	gnl|BL_ORD_ID|2184|hsp_num:0	4011			942	1140	
BGC0000394.1|Naphthyridinomycin_3 # 3812 # 5290 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.728	BGC0000394.1|Naphthyridinomycin_3 	3812	5290	-	Loose	600	271.937	Streptomyces venezuelae rox	38.81	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGCCGCCGTCCCCCCAGGTGCTCATCGTCGGCGCCGGACCCGCCGGGCTCGCGCTCGCGGCGGAGCTGGCCGGCTTCGGCGTCTCCTGCCAGGTGGTCGACAAGCGCACCGGGCGCAGCCGGCTGTCCCGCGCCTGCACGGTCGAGCCCCGTACCCTGGAACTTCTCGACATGCGCGGCCGGGTGGGTGATCTGCTGGCGTGGGGGCGGGAGTGCCCGCATCCGCCGCTCGGCAACGAGGACGGCTACCTGGACTACGGGCTGCTCGACACGCCCTTCCCGTTCAGTCTGTCCATCCCGCAGGCGCGGACCGAGGACGCGCTGCAGGCCGCCGCCGAGAAGGCGGGCGCGCTGCTCCTGCCCGGGACCGAGATGACCGGGCTGTCGCAGGACGACGACGGGGTCGACGTCGAGCTGACGGGTCCGGAGGGTCCGGCCACCGTCCGGGCCCGGTACGTCGTCGGCTGTGACGGGGTGAACAGCACCGTTCGTGACGCCGTCGGCGTGGAGTTCGACGGCTGGAACTACGACCAGTCGCTGATGATGGCCGACGCCCGGCTGAGCAGTCCCCCGGGGCCGGCCGAGTACGCGCGGATCACCCGGCGCGGCATGGCCGCCCTGTTCCCGTTCCGCGACGGCACGTACCGGGTCATCGTGCTGGACCGCGAGAAGTTCGCCGTACCCGCCGACGAGCCGCTCACGCTGGAGGACCTGAGCGAGAGCTGCGGCGCCATCCTGGGCTCGGACATCGGCATCCACGACCCGCTGTGGCTGTCCCGGTTCCGCAGCTCGCAGCGGCACGCCAAGAGGTACCGGGTCGGCCGGGTGCTGCTCGCCGGGGACGCCGCGCACACGCACATCCCGTCCGGCGGACAGGGGCTGCAGACCGGTATCCAGGACGCGTTCAACCTGGGCTGGAAGCTGCGGGCGGTGCTCGACGGATGGGCGCCGCAGGGGCTGCTCGACAGTTACGAGGCGGAGCGGTACCCGATCGCGGCGGAGACGCTGCGCAAGACCGACCTGTCCTTCCGCTTCGAGACCTCCGACAGTCTTCCCTCGCGGGTGCTGCGGAAGGCCGCGATGTGGTCGATGCGGATCAAGCCGGTGCACCGGCTGAACGTGCTGCATCTGTCGGGGCTGACCCTGCGTTACCCGGCGGAGAAGCGTGACCGGTGGACGGGCCGACGGGTACCGGACCGGCCGCTCGTGACGGCCCCCGGCGGCCCGGAGCGGCTGTACGAGTTGTTCCGGGGCGGTCATTTCGTGCTGACCGGCACGGAGGGCTGTCCGCCGGCCGCCGCGGGCTGGGAGGCTCGGCTGCGTACGGGCGTGCTCGCCGAACCCCTCGGCGCCGGGTGGCCCGCGCATGTGCTGATCCGGCCCGATGGATACGTGGCCTGGGCGGGCGTCGAACCCGGCCGCGGGTTGACGAGGGCGCTGCGCCACTGGTGCGGTGAGCCGCGCACGGTCGCCGGCTGA	MPPSPQVLIVGAGPAGLALAAELAGFGVSCQVVDKRTGRSRLSRACTVEPRTLELLDMRGRVGDLLAWGRECPHPPLGNEDGYLDYGLLDTPFPFSLSIPQARTEDALQAAAEKAGALLLPGTEMTGLSQDDDGVDVELTGPEGPATVRARYVVGCDGVNSTVRDAVGVEFDGWNYDQSLMMADARLSSPPGPAEYARITRRGMAALFPFRDGTYRVIVLDREKFAVPADEPLTLEDLSESCGAILGSDIGIHDPLWLSRFRSSQRHAKRYRVGRVLLAGDAAHTHIPSGGQGLQTGIQDAFNLGWKLRAVLDGWAPQGLLDSYEAERYPIAAETLRKTDLSFRFETSDSLPSRVLRKAAMWSMRIKPVHRLNVLHLSGLTLRYPAEKRDRWTGRRVPDRPLVTAPGGPERLYELFRGGHFVLTGTEGCPPAAAGWEARLRTGVLAEPLGAGWPAHVLIRPDGYVAWAGVEPGRGLTRALRHWCGEPRTVAG	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	103.36	gnl|BL_ORD_ID|4833|hsp_num:0	5820			9	1395	rifampin; rifaximin; rifapentine
BGC0000394.1|Naphthyridinomycin_5 # 6590 # 6847 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.736	BGC0000394.1|Naphthyridinomycin_5 	6590	6847	+	Loose	1300	22.3274	mdtO	42.31	3003549	protein homolog model	n/a	n/a	nucleoside antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCTGAACTGACCGAGCCGGCCGACCTGAGCGGACTGGCGGGCCTCGTGGCCGAGGTGCTCCAGATACCCGCCTCCGAGGTGACGGAGGAGACCGGGACCGCCACCACGGCGGCCTGGACCAGCCTGCGACACGTCCAGATCGTCTCGTGTGTCGAACGCGCCTACGGTATCCGGCTCACCGCCCGCGAGGCGCGCCGCTGCCGGAGCGTCGGCGCCCTGCGCGCGGCGCTCACCGCGAAGCGGGGGGCGCTGTGA	MAELTEPADLSGLAGLVAEVLQIPASEVTEETGTATTAAWTSLRHVQIVSCVERAYGIRLTAREARRCRSVGALRAALTAKRGAL	MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLAVLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLMRTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPSRAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQNAWWQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRISESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMAADAFTNPDYMRYAVKTLLACLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVMPWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIRDRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGTLGMLSKVMRIPRQQEVTALRTYLQIRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDLLHAWDATWNSAQALDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLFARLPDWTAPALTPATEQAQGATQ	12.45	gnl|BL_ORD_ID|1893|hsp_num:0	2056			1521	1599	acriflavine; puromycin
BGC0000394.1|Naphthyridinomycin_6 # 6844 # 9018 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.727	BGC0000394.1|Naphthyridinomycin_6 	6844	9018	+	Loose	600	29.261	OprZ	39.06	3004142	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACCCGTCCCGCGCCCCGCGTGGTGGAGGCGCTCAACGCGGCCCTGCACCGCCTGTTCGAGGAACGGTCCTCACTGCATCTGCTCGGCGAGGACGTGCGCGACCCGTACGGTGGTGCGTTCAAGGTGACCCGAGGTCTGTCGACCCGTCACCCGGACCGGGTGCTCTCCACTCCGATCAGCGAGGCGGGCATCACCGGCGTGGCGGGCGGTCTGGCGCTCGCGGGCGACCAGGCGATCGTGGAGATGATGTTCGGCGACTTCGCCGCGCTCGCCTTCGACCAGATACTCAACTTGATCTCGAAGTCGGTGACCATGTACGGCGACCGGGTGCCGATGCCGGTCGTGGTGCGCTGCCCCGTCGGCGGCAACCGTGGTTACGGTCCCACCCACAGCCAGAGCCTCCAGAAGCACTTCGTCGGCGTGCCCAACCTGGCGCTGTACGAGACGAGTCCCTTCCACGACCCGTACGCGCAGCTCGCCGAGGGCCTCGACCGCGGACCCGCGATGCTCTTCGAGGACAAGGTCCTCTACACCCGGCGGATGTTCCGTGACGGGGTGGTGGACGAGCACCACCGGTTCGCGATGCGGGGCGGGTCCACCGGCTGGGCGCACGTGTCCCCCATGGACGGCACTGTCGCCGACGTGGTGCTGATCTGCCCCGGCGGCACCACGCACCGGGCCCTCGACGCCGCACGGATCCTGCGCGCCCGCGGGATCGCCGCGCATGTCCTGGTCCCCGCCCGGCTCTACCCGCCCGACCTGGAGCCGGTGCTGCCGCTGCTGGCGGACGCCCGGCTGGTCGCCGTGGCGGAGGAGAGCACCGAGGGCGGTACCTGGGGCGCCGAGATCGCCGCCCGGGTGCACACGAGGATCTGGTCGCATCTGCGCTCGCCCGTGCTGCAGTTGAACTCGGCCGACTCGGTGGTGCCGACCGCGCCGCACCTGGAGTCGCGGGTGCTGCTCGGCGCGGAGCGGATCGCCGCCGAGATCGAGAAGGGCGCGGCCCGGTCCCTGCAGCCCCGCGGGCCGGCCGCCCCGCTCGTGACCGCCGGGTCCGAGACCGCCGGGGCGGGGGCCGGTGAGCAGCCGGCAGCCGCCGCTGTGGACAGTGCCGAGCCGGCGGCCGGGGCGCCGGTCGCCGTGCCCAAACTCAACAACAACGACACCGCCTACCTGGTCGTCCGGTGGTTCGCCGACGACGGCGCGTACATCGGCGAGGGGGACCCGCTGGTCGAACTGGAGACCTCCAAGGCGGTCGAGGAGATCGCCGCACCGGCTGACGGGCACCTGCGGATACGCGCCGCGGAGGGCAGTGAGGTCGAGGTCGGGGACCTCCTCGCCGAACTCTTCGCCGAGCCACCCGCCGCCCCGGCGCCAGACACCTTGGCGCTCACCCCCTCCGACGAGCGCGTCGCCGCCCCCGTGCCCGCGGCCGTGAACCCTACCGTGGCCCCTCCCGCCCAGGAGCCCGCCCCCGCCGCCCGTACCCATGTGCTCGACCGGGCCCAGCAGGGAACCGCCGCAGTGGTCACCCGTGCCCACCGGGAGGTGCCCGTCGCCTTCGCCGCCGTCGAGGTCCGCGTGGACCCGGTACTGGCCAGGCTGCGCACCCTGTCCGACGAGACCGGTGCCGAGGTCGGACTGCCGGAGGCGGTGGTCAAGGCCGTGGCCGCCGCGCACCCCGACTTCCCGCACCTGTTCGGCACCCTGGTGGACGAACGGACCGTGCGGCTCGCCGACACCGTGGACATCGGCGTCACCGTGGACGCCGGGAACGGTCTCTACATCCCCGTGCTGCGGGACTGTGCCGGCCGTTCCCTCGCCGACCTCTCCGACGATCTCATGGACTTCCGGATGAAGGCGTTCCGCGCCGAGTTCACCGCGGGCGAGCTGTCCGGCGGCTGTCTGAGCGTGTCGCTGAACACGGAGCCCGGTGTCCTGTTCGTCCAGCCGATCGTCATGGCGCCGCAGCTCTGCATGGTCTCGGTGGGCGGCCGGCTCACCCGGCTCGTCCTCGAGGACGGGGTGCCCACCTCCACCACCGTGGTCACCCTCGGACTCGCCTACGACCACCGGGTGGTCAACGGACGGGACGCGATCGCCTTCCTGCGTGCCGTCGCGGACGCACTGCACGACGCGGAAAGGCTCGTCGCATGCGCCGGCCCGCAGTGA	MTRPAPRVVEALNAALHRLFEERSSLHLLGEDVRDPYGGAFKVTRGLSTRHPDRVLSTPISEAGITGVAGGLALAGDQAIVEMMFGDFAALAFDQILNLISKSVTMYGDRVPMPVVVRCPVGGNRGYGPTHSQSLQKHFVGVPNLALYETSPFHDPYAQLAEGLDRGPAMLFEDKVLYTRRMFRDGVVDEHHRFAMRGGSTGWAHVSPMDGTVADVVLICPGGTTHRALDAARILRARGIAAHVLVPARLYPPDLEPVLPLLADARLVAVAEESTEGGTWGAEIAARVHTRIWSHLRSPVLQLNSADSVVPTAPHLESRVLLGAERIAAEIEKGAARSLQPRGPAAPLVTAGSETAGAGAGEQPAAAAVDSAEPAAGAPVAVPKLNNNDTAYLVVRWFADDGAYIGEGDPLVELETSKAVEEIAAPADGHLRIRAAEGSEVEVGDLLAELFAEPPAAPAPDTLALTPSDERVAAPVPAAVNPTVAPPAQEPAPAARTHVLDRAQQGTAAVVTRAHREVPVAFAAVEVRVDPVLARLRTLSDETGAEVGLPEAVVKAVAAAHPDFPHLFGTLVDERTVRLADTVDIGVTVDAGNGLYIPVLRDCAGRSLADLSDDLMDFRMKAFRAEFTAGELSGGCLSVSLNTEPGVLFVQPIVMAPQLCMVSVGGRLTRLVLEDGVPTSTTVVTLGLAYDHRVVNGRDAIAFLRAVADALHDAERLVACAGPQ	MKPVAMTLLALALSGCSLAPTHERPAAPVPAQYDTPAQPGQAAAPQDWRAYFNDPALQAWIAAALANNRDLRVAALRIEEARALYGVQQSERLPAIDASGEFSRGRATEPGQPRTPVSNRYRAAVGITAFELDFFGRVRSLSDAALARYLASEEAHRAATLALVAETATAYFNQRSLAEQLRLTDDTLALRETTLKLTQRRYDAGLETAIGLRTAQMLVESSRATRAELTREASLARHALGLLAGDFALPLGVDPTPLESQSLTPLAAGLPSELLTRRPDLRQAEQALRAANADIGAARAAFFPSVQLTTDIGTTADRFSDLFSGGTGGWSFAPRLTLPIFNAGRNRANLSLAETRKHIAVAQYEGSIQAAFRDVADALSARDALRDQIEAQRKVRDADRERQRLAERRYARGVANYLEMLEAQRSLFESEQEFIRLQQRRLVNAVDLYKALGGWDDGSSPAS	156.37	gnl|BL_ORD_ID|2408|hsp_num:0	2796			48	237	erythromycin; cefepime
BGC0000394.1|Naphthyridinomycin_7 # 9114 # 10118 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.732	BGC0000394.1|Naphthyridinomycin_7 	9114	10118	+	Loose	380	26.5646	AcrS	45.45	3000656	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGCGTACGGGTTGACCGCCTTCGGCACGGCGCTCGGCGAGCAGACCGCCGTCAAGGACGTGGTGGCCGAATACACGGAGGATGTCGAGCGCGTCCTCGGATACGGGTACGACTGCATCCACCGGGCAGCGCCCGGCACCAGCGTCACCGACCTCGCCGTCGAGGCCGGGCGGCGGGCGCTGACGGGGGTGAACCCCCGCGAGGTGGACCTGCTCGTCCTCGCCCTGACCGACCTCGCCGACCATCTGTACTGGGACGCGGCGGCCCGGGTCCAGTGGGAACTCGGCCTGAGCCGGGCCGAGGCGGTCCTCGTCGACCAGGGCTGCGCGGGCGGGGTCACCGCCTTCGACACCGTCGCGGGACGCTTCGCCACCCATCCCGGCTACGGCACGGCGCTGGTCGTCGGCGCCAACCGTACCGTCGAGGCGTACTGGAACCGGCTGGACACCCACTCGCTGCTGTTCTCCGACGGGGCCGCCGCCGCCCTCGCCGTACGCGACGCGCCCACCCTGCGGTGGCGCGCCTCGTACGCGGAGACGGACGGCCGGTACGCCGACTTCTTCCGGATGGACGTCGGCGGCGCCAGGCAGCCCTTCGTGCCCGGCGCCGAGACACCCTCCGTACGGGACTCCTGGGACGTGGTCGAGTACTTCCAGCACGACGCCGAGCGACTGGCCGCCTACGCGGAGGAGATCGACGACCGCACCGCGCGCGCCGTGCACCGGGCCTGCCGTCAGGCCGGGTGCGTCGAGGAGGACCTGGCCTGGCTCCTGCTGCTCAACGACAACGCCCGGGTCCTGGCGGCGCAGGCGGAACTGATCGGGGTACCGCTGGAGCGCACCAACACCCGACTGGCGCGCCGGCACGGGCACTTCGGCGCCGCCGACCACCTGTTCTCCCTGGCCCGGACGTACGAGGCCGGGGAGCTGTCGCCCGGGGACCTCGTGGCTCTCGGGACCAATGGCCGGGGCATGCACTGGGCGTGCGCGATCCTCCAGTGCTGA	MAYGLTAFGTALGEQTAVKDVVAEYTEDVERVLGYGYDCIHRAAPGTSVTDLAVEAGRRALTGVNPREVDLLVLALTDLADHLYWDAAARVQWELGLSRAEAVLVDQGCAGGVTAFDTVAGRFATHPGYGTALVVGANRTVEAYWNRLDTHSLLFSDGAAAALAVRDAPTLRWRASYAETDGRYADFFRMDVGGARQPFVPGAETPSVRDSWDVVEYFQHDAERLAAYAEEIDDRTARAVHRACRQAGCVEEDLAWLLLLNDNARVLAAQAELIGVPLERTNTRLARRHGHFGAADHLFSLARTYEAGELSPGDLVALGTNGRGMHWACAILQC	MAKRTKAEALKTRQELIETAIAQFAQHGVSKTTLNDIADAANVTRGAIYWHFENKTQLFNEMWLQQPSLRELIQEHLTAGLEHDPFQQLREKLIVGLQYIAKIPRQQALLKILYHKCEFNDEMLAEGVIREKMGFNPQTLREVLQACQQQGCVANNLDLDVVMIIIDGAFSGIVQNWLMNMAGYDLYKQAPALVDNVLRMFMPDENITKLIHQTNELSVM	151.82	gnl|BL_ORD_ID|601|hsp_num:0	520			405	471	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000394.1|Naphthyridinomycin_10 # 13240 # 14706 # -1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=15bp;gc_cont=0.716	BGC0000394.1|Naphthyridinomycin_10 	13240	14706	-	Loose	1000	26.1794	HelR	38.71	3007208	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target protection	helicase-like RNA polymerase protection protein	GTGGCCGCGCACTGGGAGGAACGCCGCTTCTCGGTCCTCGAGGAATGGCTCGACATAGGGCTGACTCTCGGCCGGCACGCGGAACTCATCAGTGAACTCAAACCGCTGGTCGCCGAATACCCGATGCGCGAGCGGCTGTGCGCCCAGTTGATGACCGCGCTGTATCAGTCCCAGCGTCGCGCGGAGGCCCTGGCCGTCTACCGCAACAGCCGTCTGGCCCAGATCAAGAACCTGGGACTGGAGCCGAGCACGGGACTTCAGGAACTCCACCAGAAGATTCTGGCCGGCGAGCCGATCGCCCCGCCGCCCGCCGTCGTGGCGCACCAGCCCTGGCCCGGCGCCAAGGTGCCCGCTCAGCTGCCGCCCCGCATCAAGGACTTCACCGGCCGGCGCGATCTGCTCCAGCGCATCACCTCGGACCTGCGCTCGGGCGGCGAACCCCGTGTGGTGGCGCTGGCGGGATGCGGCGGCACCGGCAAGACCGCCCTCGCGATCCACGCGGGTCTCGCCCTCCAACAGCACTTCCCCGACGGCCAGCTCTACGCCGACCTTCGAGGGCACACCGACCCCGTTCACCCGCAGGAGGTGCTGAACGGCTTCCTCGACGCGTTCGGAGTGCCGGAGCATCGGATCCCCGCGGGTCTCGCCGCCCGCGCCGCGCTGTTCCGCAGCATCACCGCCAGCAAACGGCTGCTGATCGTCCTGGACGACGTGGCGGAGTCCACCCGTTACGAGGCCCTGCTGCCCAGCGGCGAGAGCGCGGTCCTGTGCACCGGCCGGGCCAGTCTGCTGAAGATCCCCGGCCTGACCGAGTACCGCGTCGACGGGCTGCCCACCGACGAGGCACTGGACCTGCTCGCCTCCCTGGCGGGCGTGGAGCGGGTGTTCGCCGAGGTCGACAGCGCCCGGCGGATCGTCCAGTTCTGCGGGCACCTGCCGCTCGCCATCCGGGCCGCCGGAGCCCGGCTGCGGGCCCGCCCCCACTGCACTCTGAGCAGCTTCACCGCCCGTCTGGCGACACGGCAGGACCGGATCGCCGAACTCTCCATCGGCTCGCTGGACATGGGAGCGCGGCTCGACACCACCGTGGAGCAACTGTCCCCGCCCGCGTACCGGTTGTGGCTCCGGCTCAGCATGTGTGACGTGGAGTCCGTCCCCGAGTGGATGGCCTCCGCCGTCTCCGACCGCCCCGGCGAGGACACCCAGCGACTGCTGGACGCCCTGGTCAACGCCCACCTACTCGCGGTCACCCAGGACCGGGCGCCGGACGGCCCGCGCTACTCGTTCAACCCGCTGGTGCGCGACCACGCCCGGCAGCGAGCCGCGACGGAGCTCGGTGCGCTCGCCGGACAGGACGTGGTGGAGCGCATCGCACTCGCCCCGCCCGGGCGGAAGGGCGCAGCCGGGGTGTCCGGCGCGTTCCGGCCGGACAAGGAGTACACGGTCCATGGCACTCAGGCGGTATGA	MAAHWEERRFSVLEEWLDIGLTLGRHAELISELKPLVAEYPMRERLCAQLMTALYQSQRRAEALAVYRNSRLAQIKNLGLEPSTGLQELHQKILAGEPIAPPPAVVAHQPWPGAKVPAQLPPRIKDFTGRRDLLQRITSDLRSGGEPRVVALAGCGGTGKTALAIHAGLALQQHFPDGQLYADLRGHTDPVHPQEVLNGFLDAFGVPEHRIPAGLAARAALFRSITASKRLLIVLDDVAESTRYEALLPSGESAVLCTGRASLLKIPGLTEYRVDGLPTDEALDLLASLAGVERVFAEVDSARRIVQFCGHLPLAIRAAGARLRARPHCTLSSFTARLATRQDRIAELSIGSLDMGARLDTTVEQLSPPAYRLWLRLSMCDVESVPEWMASAVSDRPGEDTQRLLDALVNAHLLAVTQDRAPDGPRYSFNPLVRDHARQRAATELGALAGQDVVERIALAPPGRKGAAGVSGAFRPDKEYTVHGTQAV	MRVLSSVDQLDGTSAFDLPDRLSAKTDPALIAADERHFSAIAKSLAETITELSDRLDATRKAPGGVGREAMDRDAEIHRLTGRLRTLRRFGLDLCLGRIVTADDAEPVYVGRLGLTDSTGRRLLVDWRSPAAEPFFAATHADPMGLTSRRRYRWTGGRVSDYWDEVFTADGLEEHAALDDQSAFIASLGSSRSPQMRDVLATIQADQDAIIRAGSRGTLVVDGGPGTGKTVVALHRSAHLLYADPRLGHRRGGVLFVGPHQPYLAYVADVLPSLGEEGVRTCTVRDLVAEGAGAAVERDAEVARLKSSADMVRAIEAAVRFYEEPPTQRMTVSTDWADVRLTADDWAEAFDAPEAGTPHNEAREQIWEELGSILLGKLGDEVPEEEFRRALRQDEELAGALHGAWPLLEAADLVGDLWSVPAYLRKCAPWLDREDVAKLQRADAQAWTVSDLPLLDAARQRLGDPEAARRRRRQQATVAAERARMADVIADVLAADDDGEGAVTMLRGQDLKDTLVDEAALTGVEPDLLAGPFAHIVVDEAQELSDAEWQMLLLRCPSRSFTIVGDRAQARHGFTESWEERLARVGLDRITVASLSINYRTPEEVMAEAEPAIRAALPDANVPTSVRSSGVPVLRGPVEELDTIVDEWLAANADGTACVIGAPRFRPGPRVRSLTPSLSKGLEFDLVVLVDPEDFGGGIEGAVDRYVAMTRATKQLVILTSS	67.59	gnl|BL_ORD_ID|4837|hsp_num:0	5819			588	747	rifampin; rifaximin; rifabutin
BGC0000394.1|Naphthyridinomycin_11 # 15291 # 15413 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.569	BGC0000394.1|Naphthyridinomycin_11 	15291	15413	+	Loose	730	20.4014	mexX	33.33	3003034	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCTATACCCCACTTGGGCGCCGCCAAATGGGTCACCTTGGCCGAGTCTTTCTGTCAGCGGCGCAAGAGTGCCGGTGTGCCGAGAGAGAGGGAGGAAGGCTTGAATAGGACGGTTTATTGA	MSIPHLGAAKWVTLAESFCQRRKSAGVPREREEGLNRTVY	MDRLAARLLAALVALFLLGCEEAADAGKTAEAPAEVGVIVARPAPIGITSELPGRLEAYRQAEVRARVAGIVTRRLYEEGQDVRAGTVLFQIDPAPLKAALDISRGALPGRGQPRAAADKLKAYADLIKDRAISEREYTEAQTDARQALAQIASAKAELEQARLRLGYATVTAPIDGRARRALVTEGALVGEDSPTPLTRVEQIDPIYVNFSQPAAKSRHAAGDPRRPGEGCRRQGHRRAPGPGRRQRVPLAGELLFIDLAVDPGTDTIAMRALFRNPHRELLPGGYVQVRLQRAVNPQAITVPDALIRTAQSAVVKVVNPKGLVEDVEVRADTLQGRDWIISRGLKGGEWVIVENAAQHAAGSSVQAVVRQPASADAPSPLAASPAGQ	10.28	gnl|BL_ORD_ID|306|hsp_num:0	334			621	702	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; chloramphenicol; arbekacin; norfloxacin; ofloxacin; gentamicin
BGC0000394.1|Naphthyridinomycin_12 # 15407 # 18046 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.753	BGC0000394.1|Naphthyridinomycin_12 	15407	18046	-	Loose	1000	124.79	almE	25.83	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCCCGCGTCGCCCGTGTCCCGGTCCGTGCGCACGCCTGTCCCGGCGGACGGCCCGGTGGATGGTCCTCCGGCCGGACGGGCCGACGTGCCCGAGGGCGGACGCGGCGGTTTCACCGCCGGCTGCTGGGTGGTCGACGGCCCGCTCGATCCGGGGGCGCTCCGGGTCCGGGTCGCGGGCGGCGGCCAGAAGGTTCCGCTCACCGTGCTCGGCCCGGGGAGCGTCGGGACGGACCGTGAGGAGTGGGGCGAGCTCATCCGTGAGGAGGCGGCCGCCGCGGAGGCGGAGCCGGGCCCGGCCCGCGTGCTGCTGGCCCGGCTCGACGGGGAGCGGTCCCTGCTGGTGGTGGTCACGGAGGATGCGCTGCCGCCGGCGGCGGTGATGCGGTGGCTGCTGACGGACGACGCCCCGTTCCCGGCGGTCGGCACGGGGCCTGAAACCCTGTCACGGGCCGCCGCCGGGCCGGCGGACGGGCAGTCCGGGGCCGCCGGGCGCGAGCCGTCGGGTCTGCCGGCCGGCGGTGACCGGGCCTCCGGGTACGCCGGAACGGTGCGGGTCCCGGCCGGGCGGGCCGCCGAGCGGCTGCGCACCGCCGGTGTACCCGTGGAGGCCTCGCTGGCCGTGGCCCTGGCGGTGCTGCTGGTCCGCTGCGGCGGCGCGCCCGGTACGGGGATCGTCGTCGCGTCCGACACACCCGTGGCGGTCGCCCCGCGCGTGGCCGAGAGCATGTCCGGGACGGTCGAACTGCGCGCGGGCGGGCACGCGCTCGCCTCGGGTGTGCCGGTCCACCCGGGGTTGCACGCGGCGCTCGCGGTGTCGCCCTGCGGAGTGACGGAGCCGGAACGGGTCGGCGCGTACACCGCGTCGGCGGTCCGGCCGCCGGACGCGGTGGCCCACCACGGGCTGCTGGTCCTGCTGGAGGACGACCGGCTGCGGATGGACTACGACACCGGTCTGTACGAGGAAGGCGCCGTGGTCACGTTCGCTGCGCGGCTGCTCGCCGTCCTGGAAGAGCTGCTCGACGACCGGCCGGTGCACGGGATCGTCGCGGCCGGGGCGGCGGAACGGGCCGCGCTCGCCGAGTGGTCGCGCGGTGCCGAGGCGGCTGTTCCCGCCGTCTGCCTGCACACTCTGGTCGAGGAGCACGCCGCGCGGACGCCGGACGCGCCGGCCGTGCTGTGCGGGGACACCGAACTGACCTACGGACGGCTGGACGAGGACGCCAACCGGGTGGCCCGCCTGCTCCGTGCGGCCGGGGTCGGTGCCGGAGGGCTCGTGGCTCTGCTGACCGAGCGCGTGGCCTGGTCGGTGACGGCGATGCTGGGCACGCTGAAGGCCGGTGCCGCCTACGTACCGATCGAGCCGACGTATCCGCCCGAGCGCGTCCGGCGCATCCTCGACGACTCGGGCGCCGCGGTGCTGCTCGCCGACCGGGAGCCGGAGTACGCGGTGCCGGTGCCGGTGCTCGTGGGCGGGGAGGCGGCCGGGCTGCCCGGCACCCCGCTCGGTGTGCCGGTCACCCCCGACGATCTGGCGTACGTCATCTACACCTCCGGTTCCACCGGTACGCCCAAGGGCATCGGCGTGCACCACCGGGCGATCGTGGCGTCCACGGCGGCCCGTGCGGTGGCGGGCCCGCCGCCCGGCCGGGACCTGGTGCTGCCGCCGCTGTGCTTCGACGGGGCGGCGGGCGGCATGTTCTGGGCGCTGACCTCCGGCGGCGCGGTGGTGCTGCCCACCGAGCAGGAGGCGCACGACCCGATGGCGCTGCGGAAGCTGCTGGAGTCGGCGGCCGTCACCCATGTCCACGCCGTGCCCTCGCACTACCGGATCGTGCTGCAGGTCGCGGGCCAGGAGGCGCTCGGCCGGCTTTCGATGGTGGCCGTGGGCGGGGAGCCGCTCAGCCCGGACATCGTCGCCGAGCATCTGCGACTGTGTCCGCAGGCTCCGCTGTTCAACGACTACGGGCCGACCGAGTGCGCGGTATGGGCCACCACGCACCGCTGCGGTCCGGCGGAGGCGGCCGGCGCGGGCATCCCGATCGGGCGTCCGGTGCCCGGGTACCAGGCGTACGTGCTCGACGGCGGGCTGCGGCCGGTCCCGCCGGGGGTGCCGGGCGAGATCTGGCTCGGCGGGCCAGGGGTGGCCCGTGGCTATCACGGCCGTGCGGCGTTGACGGCCGAGCGGTTCCTGCCCGATCCGTACCGGCCCGGTGAGCGGCTGTACCGGACGGGCGACCGCGGGCTGTGGGGGCCGGACGGCCGGCTGCTCATCCTCGGCCGGGTGGACCACCAGGTGAAGGTGCGCGGCTTCCGGATCGAGCTGGGTGAGGTCGAGGCGGCGGTCCGCAGACATCCGGCCGTCGGCGAGTGCGCGGTGCTGCTGCGGCAGGACGGCGCGGCTGAACGACTTGTCGCTTTCGTCGTACTGGGATCACATGTGACCGTTCCGGAGTTGCAGCGAAAAATCGCCGAGTCGGTACCGGAGCAGATGCGCCCCCACCACATCGCCGTAGTGCCGCGACTTCCGAGAACACCAGGCGGAAAGGTGGACGCACTGGCTCTTCGCACCATGCCGCTTCCCAGCCATACGGGCATCGCCGACGACCGAACGGGCATCGCCGATAGCCGTTTTCAATAA	MPASPVSRSVRTPVPADGPVDGPPAGRADVPEGGRGGFTAGCWVVDGPLDPGALRVRVAGGGQKVPLTVLGPGSVGTDREEWGELIREEAAAAEAEPGPARVLLARLDGERSLLVVVTEDALPPAAVMRWLLTDDAPFPAVGTGPETLSRAAAGPADGQSGAAGREPSGLPAGGDRASGYAGTVRVPAGRAAERLRTAGVPVEASLAVALAVLLVRCGGAPGTGIVVASDTPVAVAPRVAESMSGTVELRAGGHALASGVPVHPGLHAALAVSPCGVTEPERVGAYTASAVRPPDAVAHHGLLVLLEDDRLRMDYDTGLYEEGAVVTFAARLLAVLEELLDDRPVHGIVAAGAAERAALAEWSRGAEAAVPAVCLHTLVEEHAARTPDAPAVLCGDTELTYGRLDEDANRVARLLRAAGVGAGGLVALLTERVAWSVTAMLGTLKAGAAYVPIEPTYPPERVRRILDDSGAAVLLADREPEYAVPVPVLVGGEAAGLPGTPLGVPVTPDDLAYVIYTSGSTGTPKGIGVHHRAIVASTAARAVAGPPPGRDLVLPPLCFDGAAGGMFWALTSGGAVVLPTEQEAHDPMALRKLLESAAVTHVHAVPSHYRIVLQVAGQEALGRLSMVAVGGEPLSPDIVAEHLRLCPQAPLFNDYGPTECAVWATTHRCGPAEAAGAGIPIGRPVPGYQAYVLDGGLRPVPPGVPGEIWLGGPGVARGYHGRAALTAERFLPDPYRPGERLYRTGDRGLWGPDGRLLILGRVDHQVKVRGFRIELGEVEAAVRRHPAVGECAVLLRQDGAAERLVAFVVLGSHVTVPELQRKIAESVPEQMRPHHIAVVPRLPRTPGGKVDALALRTMPLPSHTGIADDRTGIADSRFQ	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	158.09	gnl|BL_ORD_ID|4935|hsp_num:0	5928			135	1632	colistin A; colistin B
BGC0000394.1|Naphthyridinomycin_13 # 18127 # 19131 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=10bp;gc_cont=0.721	BGC0000394.1|Naphthyridinomycin_13 	18127	19131	-	Loose	600	27.335	OprZ	37.21	3004142	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATCCGTTACGTGGACCTGGACGCGGCCGAGGGAGCCGCGCTGGACGAACTGACCCGCTCGGTCCTGCGGGACCACGGGGCGAGCAGTTCCCCGTCCCTGCTGGACGACCTGTCGCTGGTGGCGCACCGGATGCCCCCGCGCCTGATCCGGGAGCTGCGACGGTTCCGGACCGCCGAGGAGGCGTCCTGCCTCGTCGTGCGCGGCCTTCCGGTGGACGACCGCCGGCTGGGGCCGACTCCCCTGGACTGGCGGGAGCCACCGAGGGAGCCGGAGTCGGAGGTGCACGAGGTGTTCCTGACGCTGGCGACGGCGCACCTCGGTGACATCTTCGGCTGGTCGACGCTCCAGAACGGGCGGCTGGTGCACGACGTGCTGCCGGTCCCGTCGCACGAGAACGACCAGAGCGGTCACGGCACGGTGGAGCTGGCCTGGCACACGGAGGACGGTTTCCACCCGTACCGCTGCGACTACCTGCTCCTGCTGGGGCTGCGGAACCACGACGCGGTGCCCACGGGCGTGGCCGGGGTGGACCAGGTGGTGCTGTCCGACGAGCACCGGGAGGTGCTGAGCCAGCCCCGGTTCCTGATCCGTCCGGACACCGAGCACCTCCGGCACGCCCGGACGCTGGCCGCGGACCGGGGCAGCCCGCACGCGGTGCAGCTGATGCAGGACGAACCGGAGCCGTGCGCGGTGCTGTTCGGGCACCCGGACCGGCCCTACCTGCGGATCGATCCGGCGTTCATGTCGCCCCTGCCGGGTGATCCGGAGGCGGCGGCGGCGCTGGAGGCGCTCACCGCGGAGCTGCAACGGAACCTGACCGACGTGGTGCTGAGCCCTGGTGACCTCCTGGTGATCGACAACTACCGGGTGGTGCACGGCAGAGCCGCGTTCAAGGCCCGGTTCGACGGCACGGACCGCTGGCTGAAGAAGGCGGTCGTCACCCGGGACCTGCGCAAGTCGCGGGCCCACCGGAAGTCGGCGGCGGAGCGCGTGCTGCTCTGA	MIRYVDLDAAEGAALDELTRSVLRDHGASSSPSLLDDLSLVAHRMPPRLIRELRRFRTAEEASCLVVRGLPVDDRRLGPTPLDWREPPREPESEVHEVFLTLATAHLGDIFGWSTLQNGRLVHDVLPVPSHENDQSGHGTVELAWHTEDGFHPYRCDYLLLLGLRNHDAVPTGVAGVDQVVLSDEHREVLSQPRFLIRPDTEHLRHARTLAADRGSPHAVQLMQDEPEPCAVLFGHPDRPYLRIDPAFMSPLPGDPEAAAALEALTAELQRNLTDVVLSPGDLLVIDNYRVVHGRAAFKARFDGTDRWLKKAVVTRDLRKSRAHRKSAAERVLL	MKPVAMTLLALALSGCSLAPTHERPAAPVPAQYDTPAQPGQAAAPQDWRAYFNDPALQAWIAAALANNRDLRVAALRIEEARALYGVQQSERLPAIDASGEFSRGRATEPGQPRTPVSNRYRAAVGITAFELDFFGRVRSLSDAALARYLASEEAHRAATLALVAETATAYFNQRSLAEQLRLTDDTLALRETTLKLTQRRYDAGLETAIGLRTAQMLVESSRATRAELTREASLARHALGLLAGDFALPLGVDPTPLESQSLTPLAAGLPSELLTRRPDLRQAEQALRAANADIGAARAAFFPSVQLTTDIGTTADRFSDLFSGGTGGWSFAPRLTLPIFNAGRNRANLSLAETRKHIAVAQYEGSIQAAFRDVADALSARDALRDQIEAQRKVRDADRERQRLAERRYARGVANYLEMLEAQRSLFESEQEFIRLQQRRLVNAVDLYKALGGWDDGSSPAS	72.14	gnl|BL_ORD_ID|2408|hsp_num:0	2796			348	477	erythromycin; cefepime
BGC0000394.1|Naphthyridinomycin_14 # 19203 # 23657 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.719	BGC0000394.1|Naphthyridinomycin_14 	19203	23657	-	Loose	1000	137.887	almE	26.98	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAGCGGGCAGCACGAGATCAGTTCCCTGACGTCCGAGGAGAAGCGCGCGCTCCTGGCGGGCCTCCTGGACGCCTCGGCGAACGTCACCAGCAACCTGACACTCGAGCAGCGCCGGTTGTGGCTGCTGATCCAGCTGGACGAGAAGCGGCCCTGGCAGACCAGCGTCGCGGTGCGGCTGACCGGAAGGACCGACGCGGCCGTGCTCCAGCAGGCGCTGTCGACGGCCGTGCAGCGCCACGAGGTGCTGCGTACCACCTTCCGCACGGTGGACGGCCACCCGCTGGCCACCGTCAGGCCGGTGGCGTCGCTGCGGCTGCCGGTGGTCCAGGTGGACCCGGACCGGCTCGACGCCGAGCTGGCACGCATAGCGGCCTCCGAGACCCGCCGCCGGTTCGATCTGGCCCAGGGCCCGCTGGTGCGGGCGAGTCTGCTGCGGCTCGGGGAGGAGGACCACGTCCTCCTGCTGACGGTCCACCAGCTCGTGGCCGACCGGCGCTCCGTGCGGCTGTTCACCGACGAGGTGCTCACCGGGTACGCGCACCTGCTCCGCGGAAGCGGTGAGGAGGCCGCCGGGCCTGCCGCCGAGCCCCAGGCGCTGGCCGCCGCCCAGCGTGCCTGGCTGACCGGCGACGACGCCGAGAAGGACATCGAGTACTGGCGTGACCGTACGGCCGGCCTCAATGCCCTCGAGCTGCCCACCGACCGGCCCCGGCCGCCGGTGAAGACCATCGACGCCGACGTGGCGTCGGTGGCGGTGCCGCGGGAACTGCGGGACCGGCTGGAGGCGTTCACGTCCGGTACGGGGCGGCGGCTGTCCCGGCTGCTGCTCGCCGGCTGCACCGCGGTGCTGTCCCGTCATGCCGAGCAGCGCACGTTCGCCGTCGGTGTACCCGTGCCGCCGTCGTGGCAGGAGGGCGCCGAGGGCCTGGTCGGCCCGCTGGAGAACACCCTGCCGGTGCGTTTCGACCTGGACGCCGGCGAGTCCCTGACCACGCTGCTGGGGCGGACCGACTCGGCCCTGGACGAAGCCCTGGAGCACGCCCGGCTGCCGTTCGAGCAGATCGTGGAGGCGGCGCACCCGCCGCGCGACCTCAGCCGTACCCCGCTGTTCCAGGTGCTGTTCGGCTTTGAGGAGGAGTGGAGCAGCCGGGAGCTGCCGGGGGTCACCGCCCACCGGCTCGACCTGCCGGTGACATGGACCCCGCACGACATCGACCTGTACGCGGTGCGCCGCGACGGGGAACTGTCGCTGCGGGCCCACTTCAACACCTCGCTGTTCGACCGGGCGACCGTCGAGCAGTTCCTGGACCGGACGCTGCTGCTCCTGGACTCCGCGGTCGCGGACCCCGACCGCCCGCTCTCCGACCTGTCGCTGCTGTCCGGTCAGGACCGGGAGCGGCTGGAGTCGTGGAACGCCACGGCGACCGGGCGCACCGGGCCCCGGCTGCTGCACGAGCTGGTCGCGGAGGCCGCCGCGTCCCGTCCGGACGCACCGGCGCTCACGTCGAGCACGGCGGAGCTGAGTTACGCCTCCATGGAGGCGCGGGCCGAGGCGCTGGCCGCGCGGCTCGCCGGACTCGGCGCGGGCCCGGAGTCCCTGGTCGGCGTGCTGGCCGACCGGTCGGTGCACACCATGGTCGCGCTGCTCGGTGTGCTGAAGACGGGTGGCGCGTACGTGCCGCTGGACCCCTCGTACCCGGCGGACCGTATCGCGTCGATCGCGGAGGAGGCCGGGATCCGCGTACTCGTCGGCGACCAGGGGGCGTTGGACGCGCTCGGCGGAAAGGCGGCGGACCTGGAGCGGGTGGCGGTGCCGACCGCGGATCCGGACGGCCCGGTGACACGGCCGGCCGTGGAGATCGAGCCGGACAACCTGGCCTACGTCATCTACACCTCTGGTTCCACCGGTCGCCCGAAGGGCGTGGCGGTGGAGCACCGGCAGATCACGCACTCCACGCTGGCCCGTTCGATCCTCGAGGAGCCGGGGCTGCCTGAGCGCTACCTGGTGCTGGCCCCGTTCACGTTCGACGCGTCGGGCGGCGGTCTGTACTGGACGCTGATGCGCGGCGGCACGGTCGTCGTGCCCTCCGAGGCGGAGGTGCTGGACCCGAGGCTGCTCGCCGCGCTGATCCGGGACAAGGATGTCACCCATGTCGACGGGGTGCCTTCGCAGTACTCGGTGCTGCTGGACACCGAGCCGGAGCCGTTCCCCTCCGTGCGGACGACCGTGCTGGCCGGTGAGGTACTGCCGCCCAGCCTGGTCGAGGCGCACCGGCGGCGCTCCCCCGGCGTGGCCCTGTTCAACGAGTACGGCCCCACCGAGGCGACCGTGTGGGCGTCGGTTCACCCGGTGACCGCCGAGGACGCCGAGTCCGGCCGGGTGCCGATCGGCCGCCCGATCCCCGACACCCGGGTGCATCTGCTGGACAAGCGGCTCAACCCGGTGCCGCCCGGTGTTCCCGGCGAGCTGTACATCGGCGGCGGCGGTGTGGTCCGCGGCTACGTCAAGCGGCCGGGGATGACGGGCGGCAGCTTCCTGCCCGACCCGTTCTCCGAGGAGCCCGGTGCCCGGATGTACCGGACGGGGGACCTCGCCCGCTACCGGCAGGACGGCAGCATCGAGTTCCTGGGCCGGGCCGACACCCAGGTCAAGATCCGCGGCTTCCGGATCGAGCTGACCGAGATCGAGAACGTCCTGCTGCGCCACCCGTTGGTCGCCGAGACCTCGGTGATCGCCCGGGAGGACCAGCCGGGCGTGCCGCGCCTGGTGGCGTACGTGGTCCCCGTCGTCGGCCGGGTGGTGACCAAGGAGGCCTTGATCAAGCATGTGCTGGCGCAGGTGCCGGACTACATGGTGCCCAGCGCGTTCGTGACGCTGGAGCGGATGCCGCTCACCCCGAACGGCAAGATCGACACCGCCGCGCTGCCCGCCCCGGACCTCGGCATCGAGGACTTCGTGGAGCCGGGGACGCAGCTGGAGGCGGAGATCGCGGAGACGTTCTGCTCGCTGCTGGGCGTCTCCAAGGTCAGCGCGGTGGCCGACTTCTTCGAGCTCGGCGGGAACTCGCTGCTGGTGGCGCGGCTCACCGCCCAGCTCTCCCGGACGCACGACGTGACGCTGCCGGTCGAGCAGATCTTCCGGGTGCCCACGGTCGCCGGCGTCGCCGCGGCCATCGAGGAGGACCGGCGGCAGCGGGACAACGTGGACAGCGAGGTGCTGTACGCGCAGCAACTGGAGGAGCTGCACGCGGAGATCACGCTGCCCGAGGAGATCGCCCCCGGGGACCTGCCGCACTCGGAGTGGTTCGCGCCGCGCCACGCGCTGGTCACGGGCGCGACCGGCTACCTGGGCGCGTTCCTGGCGGTGGAGCTGATCCTGCGCACCGACGCTCTCGTGCACTGCCTGGTCCGGGCGGAGAACGAGGAGGAGGCCTGGGAGCGGATGGAGGCGACGCTCCGCAAGTACCACGCGTGGGACGAGTCCTACCGGTCCCGGATGCGGATGGTGGTCGGTGACCTGGCCAGGCCGCGGCTCGGCCTGGGCGAGGAGGAGTTCGCCGCCGCCGCGGCCGAGCTGGACGTGATCTACCACAGCGGCGCGGTGGTCAACTTCACCTACCCGTACGAGGCCGCCCGGCCGGCCAACGTCGAGGGCACCAAGGAGGTGCTGCGGCTCGCCACGACCACGACGCTCAAGTCGGTCCACTTCGTGTCCAGCGTGGACGTGTTCATGGGCACCGGGGCGGAGCGGCCGTTCACCGAGGAGGACCTGGACAGCCGTCCCATCCGGATCCCCACCGGCTACCCGCGCAGCAAGTGGCTGGCCGAGAGGATCGTCTACCTGGCCCGTGACCGCGGCATCCCGGTGACCGTGCAGCGGCCGTGGATGATCACCGGCCACACCCAGACGGGTGCCTCGCACCACACCGACTACCTGTACGTGTACCTGCGGGGCTTCCTGGACCTCGGGGTGCTGCCCCTCTACAACGATGTCATCAACGCGGTGCCGGTGGACTTCACGGCGCAGGCCATCGTCTACACGTCGCTGCGGGAGGAGAACTTCGGGAAGAACTTCAACATCACGAACCCGGCTCCCACCACGATGACGCAGTGCTACCAGTGGCTGCGGTCGTTCGGTTACGACCTCAACGTCATCGACGAGGAGGAGGCCCGCCAGCGGGCGCTGGGCGTCGACGAGGACCACGTCCTGTTCCCGATGACCCCGCTGCTGCGGGTCGCCTCGATGCGGCACGCCGCGCTCGACCCGGAGCTGCAGAAGCAGATCGACCCGCAGGACGAGTGCCGGGTGCTGACCGAAGCTCTCGAGGGGTCGGGCATCAGCTGCCCGCCGGTGACCGAGGAGTGGGCGCACGCCTGCTTCCGGTTCCTGGTCGACGGCGGCTACCTGCCCGCGCCCGAGGACGTCGTCGTTCCGCAGGGATCCGTCAACTGA	MSGQHEISSLTSEEKRALLAGLLDASANVTSNLTLEQRRLWLLIQLDEKRPWQTSVAVRLTGRTDAAVLQQALSTAVQRHEVLRTTFRTVDGHPLATVRPVASLRLPVVQVDPDRLDAELARIAASETRRRFDLAQGPLVRASLLRLGEEDHVLLLTVHQLVADRRSVRLFTDEVLTGYAHLLRGSGEEAAGPAAEPQALAAAQRAWLTGDDAEKDIEYWRDRTAGLNALELPTDRPRPPVKTIDADVASVAVPRELRDRLEAFTSGTGRRLSRLLLAGCTAVLSRHAEQRTFAVGVPVPPSWQEGAEGLVGPLENTLPVRFDLDAGESLTTLLGRTDSALDEALEHARLPFEQIVEAAHPPRDLSRTPLFQVLFGFEEEWSSRELPGVTAHRLDLPVTWTPHDIDLYAVRRDGELSLRAHFNTSLFDRATVEQFLDRTLLLLDSAVADPDRPLSDLSLLSGQDRERLESWNATATGRTGPRLLHELVAEAAASRPDAPALTSSTAELSYASMEARAEALAARLAGLGAGPESLVGVLADRSVHTMVALLGVLKTGGAYVPLDPSYPADRIASIAEEAGIRVLVGDQGALDALGGKAADLERVAVPTADPDGPVTRPAVEIEPDNLAYVIYTSGSTGRPKGVAVEHRQITHSTLARSILEEPGLPERYLVLAPFTFDASGGGLYWTLMRGGTVVVPSEAEVLDPRLLAALIRDKDVTHVDGVPSQYSVLLDTEPEPFPSVRTTVLAGEVLPPSLVEAHRRRSPGVALFNEYGPTEATVWASVHPVTAEDAESGRVPIGRPIPDTRVHLLDKRLNPVPPGVPGELYIGGGGVVRGYVKRPGMTGGSFLPDPFSEEPGARMYRTGDLARYRQDGSIEFLGRADTQVKIRGFRIELTEIENVLLRHPLVAETSVIAREDQPGVPRLVAYVVPVVGRVVTKEALIKHVLAQVPDYMVPSAFVTLERMPLTPNGKIDTAALPAPDLGIEDFVEPGTQLEAEIAETFCSLLGVSKVSAVADFFELGGNSLLVARLTAQLSRTHDVTLPVEQIFRVPTVAGVAAAIEEDRRQRDNVDSEVLYAQQLEELHAEITLPEEIAPGDLPHSEWFAPRHALVTGATGYLGAFLAVELILRTDALVHCLVRAENEEEAWERMEATLRKYHAWDESYRSRMRMVVGDLARPRLGLGEEEFAAAAAELDVIYHSGAVVNFTYPYEAARPANVEGTKEVLRLATTTTLKSVHFVSSVDVFMGTGAERPFTEEDLDSRPIRIPTGYPRSKWLAERIVYLARDRGIPVTVQRPWMITGHTQTGASHHTDYLYVYLRGFLDLGVLPLYNDVINAVPVDFTAQAIVYTSLREENFGKNFNITNPAPTTMTQCYQWLRSFGYDLNVIDEEEARQRALGVDEDHVLFPMTPLLRVASMRHAALDPELQKQIDPQDECRVLTEALEGSGISCPPVTEEWAHACFRFLVDGGYLPAPEDVVVPQGSVN	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	266.91	gnl|BL_ORD_ID|4935|hsp_num:0	5928			99	1629	colistin A; colistin B
BGC0000394.1|Naphthyridinomycin_15 # 23690 # 23890 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.677	BGC0000394.1|Naphthyridinomycin_15 	23690	23890	-	Loose	400	23.483	kamB	34.04	3004102	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (A1408)	ATGGGTATCGACGACGCCGACACCGTCTTCCAGGTCGTCATCAACGAACAGGACCAGTACTCCATCTGGTTCGCCGACCGGGCGGTGCCCGCGGGCTGGGCCGCCGCAGGCCCGGCCGGCACCAAGCAGGAATGCCTCAAGCACATCGAGCGGGTGTGGACCGACATGCGTCCGCGTTCGGTCCGCGAACGCTCCGCCTGA	MGIDDADTVFQVVINEQDQYSIWFADRAVPAGWAAAGPAGTKQECLKHIERVWTDMRPRSVRERSA	MRRVVGKRVQEFSDAEFEQLRSQYDDVVLDVGTGDGKHPYKVARQNPSRLVVALDADKSRMEKISAKAAAKPAKGGLPNLLYLWATAERLPPLSGVGELHVLMPWGSLLRGVLGSSPEMLRGMAAVCRPGASFLVALNLHAWRPSVPEVGEHPEPTPDSADEWLAPRYAEAGWKLADCRYLEPEEVAGLETSWTRRLHSSRDRFDVLALTGTISP	30.70	gnl|BL_ORD_ID|2390|hsp_num:0	2770			471	609	neomycin; apramycin; kanamycin A
BGC0000394.1|Naphthyridinomycin_16 # 23936 # 27043 # -1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.747	BGC0000394.1|Naphthyridinomycin_16 	23936	27043	-	Loose	2000	31.187	adeB	34.55	3000775	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGCAGTTCCTCGTACGCCGGTGGTGTCGGCAGCGGCGAGTCGCGTGACTACGGCGACTACTTCGTGCTCCCGGCCGCGCCGGCGCAGCGCAGTCTGTGGTTCGTCTGCCAGCTGAACCCGTCGAGCAACGCCGCGTACAACGTGGTGAGCGCGGTGCGGCTGACGGGTGAGCTGGACGTCGTGCTGCTCCAGCAGGCGGTGAACGCCGTGGTGGCGCGGCACGAGAGCCTGCGCACCGGGGTAGGCCTGGTCGACGGCGATCCGCACCAGTTGGTGCTGCCGGAGGCGCTGGTGTCGCTGCCGGTGATCGACTGCGCGCACCTGTCGCCCGGTGCGGTCGAGGACCGGGTGCAGTCGCTGGCCCGGGAACAGGCGTCGGCGCCGTTCACGCTGGACGCGCCGCCGCTGCTGCGGCTGGTCCTGGTGCGCGAGGCCGCGGACCGGCACACGCTGATCGTGACGATCCACCATCTCGTGTGCGACAGCTGGTCGATGGACGTGTTCTACGCGGACCTCGCCGACGCCTACCGCGGATTGCGCGAGCGAGGCGAGGCGGGCCTCGGCGAGCCGGCGGTGCAGTACGCCGACTATGTCGGCTGGCTGGACGAGCAGTTGGCCGGGGACCGGATGGACGAGCTGATCGCCTACTGGCGGCGGACGCTGTCCGGTACGGCGCCGTTGCAGCTGCCGGTGGACCGTCCCCGTGAGCAGGGGCGCGGCGGGGACGGCGGCCGGGTGGAGGAGCGCCTGGACGGGGTGACGACGGCCGCGCTCGAGGAGCTGGCCAAGCAGTCCGGCGGCACGCTGTTCATGGTGGTGCTCACCGGTTTCATGGCGACGCTGGCCCGGGTGACGGGCCAGGAGGACGTCGTGGTGGGCACGCCGGTGGCGGGGCGGCACCATCCGGACGCGGAGGGGCTGGTCGGGTTCTTCGCGAACACCCTGGTGCTGCGCGCCAGGCTGCCGCTGTCCGGCGGGTTCGGGACGGCGGCCACCCTGGTGCGGGACGCATGTGTCGGCGCCTTCTCGCACGACCGGATGCCGTTCGACCGGCTGGTGCAGGAGATGCGGCAGACCCGTGCCCTCGAGCGCAACCCGCTGTTCGACGTGATGTTCTCCATGCCGAACACCCCTCCGGCGGAGGTGGGGTTGCCCGGTCTGACGATGGCGCCGGTGGAGCTGGAGCGTACGGCTGCCAAGTTCGACCTGTGGCTGACGGTGCTGCCGGACGGGGACGGGCTGCGGCTGCAACTGGACTACGACCGGGGCCTGTACGACGAGGCCACGGCGGCCCGGATCGTGGAGCTGCACCGGCTGGTGCTGACGGACGCGTTGCGGGACCCGGCGGCTCCGACAGGGGCACTGCCGCTGGCCGCCGACGCGGTCCCGGCGCCGGCCGCGGGCGAGCCGGACCCGGCCGCGTTCGCGGCGGGGACGACTGTGGCGGAGATGCTCGCGGAGCGTCCCGCGGACAGCGTGGTGCTGTCGTCGGCGGACGCCGTGCTGACACTTGGCGAGCTGCGTGAGTGGGCGTCGGATCTGGCCGGCCGGCTGCGCGCCGAGGGCATCGCCGGGCCGGATGTGCGGGTGACCACTCCCCCGGTGCCGTCGGCGGCGCTGGTCGCCGTGCTGCTCGCGGTGTTCGAGGTCGGTGCGGTACCCGCGTACGGGCAGCGGCACGACCGGGCGGGCGCCTTCGTGCGGCGGGCCGAGGAGGAGGACGGCGGCTGGCTGATCACCACCGGTCCGCGGTTCGACCCGGCTGAGGACACCGGGCTGTCAGGGCCGGACGCGCCGGCCTGGTCGGCGCAGGACACGGACCAGGGGGGCGCGGCGGCGGCGCTGTCGCACGGGGCCCTGGCCGCCGCGGTGGCGGCCGTCGCGGACCGGCTGTCGGTGACCCCGGAGGACGACGTGGTGCTGCTGGACGGCGGGTCCCCACCGTCACCGGTGGATCTGCTGATGCCCTTGACGCACGCCCGCAGCCTGCTGCTGTCAGGGGTGCAGCTGGCTCCTCCGGGGCCGCCCGGCGCGTTCGTCCTGGCCGTTCCGCCGACCTGGCGGAGGGTGCTCACCGAGGGCTGGGAGCCCCCGCCGGGGGCACGGCTGGTGTGTGTCGGTGAGGTGCTGGCGCCCGATCTGGTGGACATGCTCGCACGGACCGGCCGCACGGTGTTCCTGGGCCGTCCCGGCCCCGGGGCGACGGCTCCCCCGGTCGCCCTCGCCCCGCTGGACGAGGGACGGGGACGCCGGCTCGGACCGGCGCCCGCCGGTGTGGTCCGCAGTGTGCTGGACGCGCGGGGCAGGCCCGTGGCCGCCGGTCTGGTCGGCGAGCTGTTCGTCACGGACGGGACGGGCGCCGCCGTGCCGGCGGGGCTGCGGTGCCGCCGGGCCGGGAACGGGGCGCTGGAGGTGGTCGGGCCCGGTGAGGGCCGGCTGTTCGCCGGGGACCGCTCCGTCCCGGCGGCGAGCGTCGAGAGGGTGCTCAACGGGTTCCCCGGGGTGGCGGCCTCGGCCGTGACCACGGATGCCGGACAGAGCCGTCTGGTCGCCTGGCTGGTGCCGGACGGCACCGTCCCGGCCGGTACCGAGGCGGAGCGTGAGGCGTTCACCGCCGCCGTCCGGGGCCGGGCCCGGTCCGCGCTGCCCGGCTACCGGGTCCCTGCCGTGTTCGGGGTCCTGGACGAACTTCCCCTGGACCCCGGCGGCGAGATCGACCGGGGCGCCCTGCCGGAGCCCCCTGCGCAGGCGCCGCGTGAGCCGGTGGCGCAGGTGCCGCCCCGCAACGGGGTGGAGCGCCGGGTGCTGTCCCTCTTCCAGGAGGTGCTCGGGCTGTCGGTGACCGGCATGCATGCCGACTTCTTCGGGCTCGGCGGGCACTCCCTGCTCGCAGCCAAAATGCTGAGCCGCGTCCGGGCCGAGTTCGGTCTGCAGGTGCCGGTGCGCGACTTCTTCCGTCTGCCGACCCCGGCCGGGCTCGCCGCGGCCATCGAGGAACTGGAGCGCGCCCGCGACCGCAGACCGACCGCCGACGAGGCGCTGCTCGCCCAGCTCGCCGGGATGTCCGACGACGAGATCGACCAGCTCCTTCGCCATCTGAACTGA	MSSSSYAGGVGSGESRDYGDYFVLPAAPAQRSLWFVCQLNPSSNAAYNVVSAVRLTGELDVVLLQQAVNAVVARHESLRTGVGLVDGDPHQLVLPEALVSLPVIDCAHLSPGAVEDRVQSLAREQASAPFTLDAPPLLRLVLVREAADRHTLIVTIHHLVCDSWSMDVFYADLADAYRGLRERGEAGLGEPAVQYADYVGWLDEQLAGDRMDELIAYWRRTLSGTAPLQLPVDRPREQGRGGDGGRVEERLDGVTTAALEELAKQSGGTLFMVVLTGFMATLARVTGQEDVVVGTPVAGRHHPDAEGLVGFFANTLVLRARLPLSGGFGTAATLVRDACVGAFSHDRMPFDRLVQEMRQTRALERNPLFDVMFSMPNTPPAEVGLPGLTMAPVELERTAAKFDLWLTVLPDGDGLRLQLDYDRGLYDEATAARIVELHRLVLTDALRDPAAPTGALPLAADAVPAPAAGEPDPAAFAAGTTVAEMLAERPADSVVLSSADAVLTLGELREWASDLAGRLRAEGIAGPDVRVTTPPVPSAALVAVLLAVFEVGAVPAYGQRHDRAGAFVRRAEEEDGGWLITTGPRFDPAEDTGLSGPDAPAWSAQDTDQGGAAAALSHGALAAAVAAVADRLSVTPEDDVVLLDGGSPPSPVDLLMPLTHARSLLLSGVQLAPPGPPGAFVLAVPPTWRRVLTEGWEPPPGARLVCVGEVLAPDLVDMLARTGRTVFLGRPGPGATAPPVALAPLDEGRGRRLGPAPAGVVRSVLDARGRPVAAGLVGELFVTDGTGAAVPAGLRCRRAGNGALEVVGPGEGRLFAGDRSVPAASVERVLNGFPGVAASAVTTDAGQSRLVAWLVPDGTVPAGTEAEREAFTAAVRGRARSALPGYRVPAVFGVLDELPLDPGGEIDRGALPEPPAQAPREPVAQVPPRNGVERRVLSLFQEVLGLSVTGMHADFFGLGGHSLLAAKMLSRVRAEFGLQVPVRDFFRLPTPAGLAAAIEELERARDRRPTADEALLAQLAGMSDDEIDQLLRHLN	MSQFFIRRPVFAWVIAIFIIIFGLLSIPKLPIARFPSVAPPQVNISATYPGATAKTINDSVVTLIERELSGVKNLLYYSATTDTSGTAEITATFKPGTDVEMAQVDVQNKIKAVEARLPQVVRQQGLQVEASSSGFLMLVGINSPNNQYSEVDLSDYLVRNVVEELKRVEGVGKVQSFGAEKAMRIWVDPNKLVSYGLSISDVNNAIRENNVEIAPGRLGDLPAEKGQLITIPLSAQGQLSSLEQFKNISLKSKTNGSVIKLSDVANVEIGSQAYNFAILENGKPATAAAIQLSPGANAVKTAEVVRAKIEELKLNLPEGMEFSIPYDTAPFVKISIEKVIHTLLEAMVLVFIVMYLFLHNVRYTLIPAIVAPIALLGTFTVMLLAGFSINVLTMFGMVLAIGIIVDDAIVVVENVERIMATEGLSPKDATSKAMKEITSPIIGITLVLAAVFLPMAFASGSVGVIYKQFTLTMSVSILFSALLALILTPALCATILKPIDGHHQKKGFFAWFDRSFDKVTKKYELMLLKIIKHTVPMMVIFLVITGITFTGMKYWPTAFMPEEDQGWFMTSFQLPSDATAERTRNVVNQFENNLKDNPDVKSNTTILGWGFSGAGQNVAVAFTTLKDFKERTSSASKMTSDVNSSMANSTEGETMAVLPPAIDELGTFSGFSLRLQDRANLGMPALLAAQDELMAMAAKNKKFYMVWNEGLPQGDNISLKIDREKLSAFGVKFSDVSDIISTSMGSMYINDFPNQGRMQQVIVQVEAKSRMQLKDILNLKVMGSSGQLVSLSEVVTPQWNKAPQQYNRYNGRPSLSIAGIPNFDTSSGEAMREMEQLIAKLPKGIGYEWTGISLQEKQSESQMAFLLGLSMLVVFLVLAALYESWAIPLSVMLVVPLGIFGAIIAIMSRGLMNDVFFKIGLITIIGLSAKNAILIVEFAKMLKEEGMSLIEATVAAAKLRLRPILMTSLAFTCGVIPLVIASGASSETQHALGTGVFGGMISATILAIFFVPVFFIFILGAVEKLFSSKKKISS	100.00	gnl|BL_ORD_ID|800|hsp_num:0	866			2013	2178	tigecycline; tetracycline
BGC0000394.1|Naphthyridinomycin_17 # 27040 # 27813 # -1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.716	BGC0000394.1|Naphthyridinomycin_17 	27040	27813	-	Loose	1200	26.5646	tet(T)	28.57	3000193	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	GTGCGCCCGACCCGACCGAGTTCCCGCTGGTTCCGATCTTTCGGCGACGTCACCGATCCGGTCAGCGAAGTGGTGTGCTTTCCGCATGCCGGGGGCAGCGCGGCGATGTTCCGGAGCTGGCAGCGGTACACCTCGGCGTTGCAGATCACGGCGGTGCAGTTGCCGGGCCGTGAGGTACGCCTCGGGGAGCGGCCGTTCCTGGAGATGACCGCGCTCGTGGACGCGCTGGCGCCGGCGCTCGCACCGCTGACCGGGCGGCCGTACGCGTTCTACGGGCACAGCATGGGCGCGCTGGTCGCCTTCGAGGTGCTGCGGCGGTTCCGGGAGCTGGAACTGCCCTTGCCGGCGGCGCTGTTCGTGTCCGGCCGGGATGCCCCGCAGTACGCGGACCAGGAGCGGGTCCACCATCTGCCGGACGCGGAGCTGCTGGCGCGGCTGCGGGCCTGGGAGGGGATGGAGCCGCAGGACCTCTCCACCTACGACGAGCTCGTCACGCTGATGCTGCCCACCATCCGCGCCGATCTGACCCTGGCGGAGACCTATCAGCACGTGCCGGGGCCGCCGTTGCCGGTGCCGGTGCGGGTGCTGCGCGGCAGACGGGACCCGCTGGTGCGGGACGGGGACGCGGGCTGGGCCCGGCAGACCTCGGCGGACTGTTCCGTGCACGAGTTCGACGGAGGTCACTACTTCGTCCAGGACCACGAGAGGAGCGTCGTCGCCCATATCGGGGAGGCGCTCGGCGTATCGGCCGCAAGGGAGGCGGGAACCCAGTGA	MRPTRPSSRWFRSFGDVTDPVSEVVCFPHAGGSAAMFRSWQRYTSALQITAVQLPGREVRLGERPFLEMTALVDALAPALAPLTGRPYAFYGHSMGALVAFEVLRRFRELELPLPAALFVSGRDAPQYADQERVHHLPDAELLARLRAWEGMEPQDLSTYDELVTLMLPTIRADLTLAETYQHVPGPPLPVPVRVLRGRRDPLVRDGDAGWARQTSADCSVHEFDGGHYFVQDHERSVVAHIGEALGVSAAREAGTQ	MKIINIGILAHVDAGKTTVTEGLLYKSGAINKIGRVDNATTTTDSMELERDRGITIRASTVSFNYNDTKVNIIDTPGHMDFIAEVERTLKVLDGAILVISAKEGIQVQTKVIFNTLVKLNIPTLIFVNKIDRKGVCLDEIYTQIQEKLTSNLAIMQSVKIKDKGDFELTNVRDDKVIQSQIIEKLLDINDYLAEKYINGDVIAEKEYNDVFLDEINNCNLYPVFHGSALKNIGIDELLFAITKYLPTKSYNTEDLLSAYVYKIDRDEKSRKMTFLRVFSGNIRTRQDVYINGTEETFKIKSLESIMNGEIVKVGQVNSGDIAIISNANSLKIGDYIGKKYDGILDIKIAQPALRASIKPCDLSKRSKLIEALFELTEEDPFLDCEINGDTGEIILRLFGNIQMEVIESLLKSRYKIDARFGELKTIYKERPKRNSKAVIHIEVPPNPYWASIGLSIEPLPIGSGLLYKTEVSYGYLNNSFQNAVKDAVEKACKEGLYGWEVTDLKVTFDYGLYYSPVSTPSDFRNLTPYVFWEALRKAGTEILEPYLKYTVQVPNDFCGRVMSDLRKMRASIEDIIAKGEETTLSGKIPVDTSKSYQSELLSYSNGKGIFITEPYGYDIYNDKPIINDIGNDNNDSNKEGLRYLFQKQDEN	39.48	gnl|BL_ORD_ID|1954|hsp_num:0	2037			246	432	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000394.1|Naphthyridinomycin_18 # 28146 # 30125 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.711	BGC0000394.1|Naphthyridinomycin_18 	28146	30125	+	Loose	1000	59.3066	almE	24.56	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCCGAGCCCAGCTCGTCCCACACTGGTGCACACCCTCGTCACGCACGCCGCCACCCGCGGCGATCAGACGGCTTACGAGTACCTGCACGACGACGGGCGAGTGGACAGCCTCACCTACCGGGAACTCCTGGCCCGAGCCACCAAGGTGGCGCCGAGGCTGCGCGCCGACTCCGGGAACAAGGGACCCGCCCTGCTGCTCTACCCGCCTGGCCTGGACTTCGTCGTCGCCGTCTGGGCCTGCTTCCTCGCCGGGGTCCCCGCCGTTCCCGCCTATCCGCCGATCTTCGGCTCCACCGACCGCATCGCGGCCCGCTTCACCCGGATGCTCGAGGACTCCCGGGCCGGCACCCTGCTGGCCGACCCGGACGTGCTCGGACTGTTCACCGCCGGCATGAGCCCCGAATCCATGCCGCGCGTCCTCACCCTCGACGACGCCGACAACGACGGCGACGCGACCGCGGACGGGAGCCCCGACGCGGACGTCCTGGCCGGTCTGCTCCGCACCGCCGCCGCACCCGAGGACCCCGCTCTCATCCAGTACACCTCGGGCAGCACGGGACAGCCCAAAGGCGTCGTCCTGGAACACCGGAATCTCCTCGCCAACATCAGAGCGATTACCGACGTATTCAAACTGGACGAAACCGCCCGCGTGGTCTCCTGGCTTCCGCCCTATCACGACATGGGGCTCATCGGATTCATCCTCACGCCCGTCCACGGGGCATTTCCGGTTCGCTTGATGTCCCCCGTGCATTTCCTCAAGAATCCGCTCGCCTGGCTGCGACAGATCAGCGAACTCGGCATCACCCACACCGGTGGACCGAATTTCGCCTACGACCTGTGCGACCGGCGCGCCGCCTCGGCCGACCTCACCGGACTCGACCTGAGCACCTGGCGCCTCGCCTTCAACGGCGCCGAACCGATCCGCCCCGCGACCCTCCGGCGGTTCGCCGACCGCTTCGCCCCCCACGGCTTCCGCCCCGAGGCGTTCCTGCCCTGCTACGGCCTGGCCGAGGCCACCCTCATCGTCACCGGACACCACTGGACCGGACCCGACGACGGCGTGGACGAGGACGGCCGCGTCGACTGCGGCCCCGTCATCGACGGACACACCCTCGTCCTCGTCGACCCCGACACCGGCACACCCGTCCCAGAAGGCGCCGAGGGCGAGATCTGGATCAGCGGCCCCAGTATCAGCGACGGCTACTGGAACAGCACGGGCACCACCGCCGGCGAACTCTTCGGCGTCCTCGACGGCACCCGCCGTCTGCGCACCGGCGACCTCGGCCGGCTGCGCGACGGACACCTCACCGTCACCGGCCGCCGCAAGGACGTCCTCATCCAGAACGGCGTCAACCACCACGCCCACGACCTGTGTACCGCCGCGACCGAGGACAACCCCGCCGTACGGCCCACCGCCGCCGCCTTCGCCGGATCGGACGACGAGGTCGTCATCGCCGTCGAGGTCGCCGACCGGAACCCCGACACGGCGGCCCTCGCCGCCGACATCCGCACCCGCGTCCTCACCGCCACCGGCGTCCGCGTCCACACCGTGGTCCTCTGCCCGCCCCGCACCATCCCCCGCACCACCAGCGGGAAGGTCCAGCACTCCCTGGCCCGCACCCGCCACCTGGAGGGCAGCCTCGGCGGAACCGCCGTCACCGCCACACCGGTCACCGCCACCGCCGAGGACACGGAACTCCTCACCCTCTTCCTCTCCTCCCTCTTCGCCGCCGTCTGCCAGGTCCCCTCCTGCGGACCTGACGAGACGCTCGCCGCCATGGGCGGGGACTCCCTGCGGGCCGCCGAGATCGCCGCCGTCGCCGAGGACGCCCTCACCCTCGAGGTACGGGTCGAGGACGTACTCCGCGCCCAGACCCCCCGAGAACTCACCACCCGCCTCGCCCGCCGCTGGGCCGACCACGACATGCCCTACGCCGACGCAATGGAGCGCGTCAGGACGCTGATGTCCCGCGATTGA	MPSPARPTLVHTLVTHAATRGDQTAYEYLHDDGRVDSLTYRELLARATKVAPRLRADSGNKGPALLLYPPGLDFVVAVWACFLAGVPAVPAYPPIFGSTDRIAARFTRMLEDSRAGTLLADPDVLGLFTAGMSPESMPRVLTLDDADNDGDATADGSPDADVLAGLLRTAAAPEDPALIQYTSGSTGQPKGVVLEHRNLLANIRAITDVFKLDETARVVSWLPPYHDMGLIGFILTPVHGAFPVRLMSPVHFLKNPLAWLRQISELGITHTGGPNFAYDLCDRRAASADLTGLDLSTWRLAFNGAEPIRPATLRRFADRFAPHGFRPEAFLPCYGLAEATLIVTGHHWTGPDDGVDEDGRVDCGPVIDGHTLVLVDPDTGTPVPEGAEGEIWISGPSISDGYWNSTGTTAGELFGVLDGTRRLRTGDLGRLRDGHLTVTGRRKDVLIQNGVNHHAHDLCTAATEDNPAVRPTAAAFAGSDDEVVIAVEVADRNPDTAALAADIRTRVLTATGVRVHTVVLCPPRTIPRTTSGKVQHSLARTRHLEGSLGGTAVTATPVTATAEDTELLTLFLSSLFAAVCQVPSCGPDETLAAMGGDSLRAAEIAAVAEDALTLEVRVEDVLRAQTPRELTTRLARRWADHDMPYADAMERVRTLMSRD	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	118.53	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1341	colistin A; colistin B
BGC0000394.1|Naphthyridinomycin_19 # 30195 # 39491 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=10bp;gc_cont=0.702	BGC0000394.1|Naphthyridinomycin_19 	30195	39491	+	Loose	1000	134.806	almE	33.06	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGTCAGAGAACCATCAGGTATCCGCCGACCTCGGCCGCGACCTCCTCGCCCGCTGGCGTGCCCGCACACCGGACACCACCGCACCCGCCGCCCCCCAGGCCAGCCCCATCCAACTCGGCCTGCGCCTGTTCGAGGAGATCCACCCGGGCACCGCCGCCAACATCCTCCGCTACGACGCCGAGACCGACGGCACCCTCGACACCGACCGCCTCGCCACCGCCCTGCGCACCCTCGCCCACCGACACGCGGTGCTGCGCACCACCTTCCCCGAGGGGGACCGGACCCTGTGCGCCGTCACCCCGGAAGCCGAAGCCGTACCCGATCTCACCGTCACCGATCTCGCCGGGATCGGCACCGACGCCGGCCGCGCCCGGGCGCACGCCGAGGCGGACGCCCGAGCCGCCGCGCCCATGAACCTCGCGACCGGCCCCCTCTGGCGCGTCGCCGTCTGGATCCTCGCCGACGGCACCGCCCGACTGCAGTTCCTCGCCCACCACATCGTGGCCGACGGTTGGTCCCTGGGCGTGTTCCTCGCCGAACTCGACGCCCTCTACGCCGGCCGGCCTCTCGGCCCGGCCACCCCGTTGCCCGAGGTCCCCGCCACCCCCGACCCGGCCCACCTCGCCGCCTGGAGGGACCGCCTGGCCGACGCCCGACCGCTCTCACTGCCCACGGACCGACCTCGCCCGCACACCCGCCGCTTCCGCTCCGGCCACGTCGACGTCACCGTGGACGCCGAACTGATGGGCCGCGTCCAGGAGCTGGCCGACAGCAACGCGATGACACCCTTCATGGTGCTGCTCACCGCCTTCCATCTGACGCTGGCGCGGACGGCCGGGCACTCGGACATCACCGTCGGGTCACCCGTCGCGACCCGTGAACGCCACCGCGCGCCGGGAGCCATCGGCCCCCTCGCGACCATGCTCGCGCTGCGCACCGACACCACCGGCGCCCACACCGTCCGTGAGGCGCTCCACGCGGTCCGGGACACCTGCCTCGACGCGTACAGCGGCGCCCATGTGCCCATCGAGACGGTGGCGGAGCAGCTCGGCCGGCGGGGCGCGTCCCTGTTCGACGTCCTCTTCGTCCTCCAGCCGCGACCGGGCGAGGCCCGCCTCGGGGACCTGCCGGTCCGGCCGATGGTGATGGCGCCCGTCACCATCCGCAACGACGTCGAGCTGTACCTCTGGCAGGGAGACGACGGCGTCACCGGCTTCCTGGCCTACGACACCGACCTGTACTCCGCCGACACCGCCACCCTCCTCGCTGACCGCTTCCTCACCGCTCTCTCGGCGTTCGTGGAGTGCCCGGATGCTGTGGTGGCCGAGGTGGATGTGCGGTCGGTGGGGGAGCGCGAGCGGGCGGTGGCGCTGTCGGCGGGTGTGCCGTTGGCGGGTGGGGCGACGGGTCGAGTCGAGGAGCTGGTCGAGGGGGTGGTTGACCGCCTGGGTGGTGCGGGTGTGGCGGTGTGTTGTGCGGGTGAGGTGTTGTCGTTCGGGCAGTTGGAGGAGCGGGCGAACCGGCTGGCGTGGGGCTTGCGTGATGCGGGCGTGGGACCCGGCGACCTGGTGGGTGTGTTGTTGCCCAGGTCGGTGGACCTGGTGGTCGCTCTGTTGGGTGTGCTGAAGTCGGGTGCGGGTTATGTGCCGATGGATCCGGGATATCCGGGTGAGCGTGTCGACTTCATGGTCGAGGACTCGGGTGTCTCGCTGGTCTTGAGGTCGGTGGAGGACTTCCCGGACGGGGGCCGCACGGACCGGGTGCCTGTGGCGGGGGACGGTTCGGATGTGGCGTATGTGATTTACACGTCGGGATCCACTGGTCGTCCGAAGGGGGTGGTGATCGAGCACTCCCAGGTGGTGGCGATGCTGTCGTGGGCGGGCCGGGTGTTCGCGGATGGGGAGTTGTCGCAGACGCTGGCTGCGACGTCGGTGTCGTTCGACCTGTCGGTGTTCGAGATCTTCGCTCCGCTGTCGGTGGGCGGGACGGTGCATCTCGTCCCCGACAACGCGCTGGACCTGATCGCGCATCCGGGCCGATACGCGGACGTGACGCTGGTGAACACAGTGCCGTCCGTGGTCCGTGAGTTGCTCGCGGCGGGTGCGATACCTCCTCGGGCTCGGACGGTGAACCTCGCGGGTGAGCCGTTGGCTCCGGGTTTGGTGGCGGAGTTGTACGCGCATCCGGTGATCGGTGTGGTGAACAACCTGTACGGGCCGAGTGAGGACACCACCTATTCGACGCACGCGGTCACCGTCGCTGGCGATGCGCGGACACCGATCGGCCGGCCCGTCGACGGTACGCGGGCTCACGTCCTGGACGGGTCTCTGCGGCCGGTGGTTGTGGGTGCGGTGGGGGAGTTGTATCTGTCGGGGGCTGGTGTCACGCGCGGCTACCACGCCCGGCCCGCGCTGACCGCGGGGCGGTACCTTCCCGATCCGTTCTCTGCGGAGGGCGGCAGGATGTATCGCACGGGGGATCTCGTGCGCTGGCGTCCTGATGGGCAGTTGGAGTATCTGGGCCGGGCCGACGGGCAGGTGAAGATCCGGGGTCACCGTGTCGAGCTCGGTGAGGTCGAGGAAGTCCTGCGCCGGCACCCGCAGGTGTCGGAGGCGGTGGTCGTCGCCCGCCCGGACGTCACCGGGTCACTGAGGCTGATCGGTTACGTTGTCGCTCACGAGGCGGGCGGTGACGTCCCCTCCGACCTGCCCTCCCACGCACGCACCTGGCTCCCCGACTTCATGGTTCCCTCGGCCCTGGTCGGCCTCGAGGAGTTGCCTCTCCTCCCCAACGGGAAGATCGACCGCTCCGCTCTGCCCGACCCCGAGCCCGGCGCAGACCGCGCCTCCTTCCGCTCTCCGTCCGGGCCGGCCGAGGAACTGATCGCCCGCGTCTGGAGCGAACTCCTCGACGTTACTGAGATCGGCGCGGACGACGACTTCTTCGCCCTGGGCGGCCACTCCCTCCTCGCCACCCGGCTCACCCACCGGCTCGGCGAGGCCCTCGGCGCCCACATACCGCTCCACCTCGTCTTCGAACACCCCACCCTCACCGACCTCGCCGCCCACCTGGACCGACTGGGTAAGTCCCGCCCGCCCATACCGGTCACACCGCGCATCCCGAACCCCGATGGCACCGTCGTCTTCCCTGCCACGTCCGGCCAGAAGCGACTGTGGCTGCTGTGCGCCCTGGACCCGCAGGCGAATCTCGCCTACACACTGAACGGCGGTGCCAGGATCACCGGTCGGCTCGACGCCGCGGCTCTGGCACGGGCGGTCGAAGAGGTCGCCCGCCGCCACGAGGTGCTGCGGACCACCCTGCGCGAGGAGAACGGCGAGGTCGTCCAAGTCGTCCACCCCGTCTGGTCCGGTACGGAGGCAGACGATACATACGCGTCCCCGGAATGCGACGAGGCTGAACTGCTGTCGGACTGGCGTCACTCCACGGTGGACCTTGCCGAAGGCCCGCTCTTCCGCGCGCGGATCGCCCGCCGCGCCGACGATGTCCACCTGCTCCTGCTGTCCCTGCACCACACCATCGCCGACGGCTGGACACTCACCCGCCTGCTGGACGAGATAGCCGCCGTCTACGCCGCCCTCCACCAAAGCCACCCCCTGCCCCCGGCTCCCACCCTCCACTACGGCGACTTCGCGCAGATGCGAGCTGCCGAGCTGACGTCCGAGGACGACGAAGGGCTCGCTCACTGGCGTGAGCGGCTCGCGGGAGTGCGCCCTCTGGACGTTCCGACCGACCACCCGCGTCCAGCACGGCGCACCCACAACGGCGCGGCCGTCCCGGTGGAACTGAGCGCCGAGGCGGTCGGGGACATCGCACGCCGTACCGGCACGACCCCGTTCGCCGTTGTCGCCACCGCGGTCACTGTCGTCCTGGGCGTCTTGTCGGGCAGCGACGACGTGACCATCGGCATCCCGACCAGCGGCCGCACCCACCCCGACACCGCCGGCATCCTGGGATTCTTCACCAACACCCTGCCCCTGCGCCGGACGCTCGACCCGCGGGCCACGCTCGCGGAGACACTGCACGCCACCCACCACGCCCTCGTGGAAGCACACGAACACGCCGAGACGCCGTTCGAGGAGATCGTCCGGCACACGTCGCTCGGCGCCGACGGGCAGGCGCGCAGCCCCCTGTTCCAGACGATGCTGGCCCTCAACGAAGCCCCGTCACGGAACCTGCACCTACCTGGTCTGACCGTCAGCCGTCTTGACATCCCGCCGGCCGGAACCCAGTTCGACCTCTCCCTTCACCTGGAGCAGGGCGAGGACGCCATCAGCGGCTACCTCACCTACAACACCGATCTCTACGCGGACAGCACCGCCCGCTTCTTCACCGAGCGCCTCGCCTCCGTCGTCTCCGTGTTGGTGGAGTGCCCGGATGCTGTGGTGGCCGAGGTGGATGTGCGGTCGGTGGCGGAGCGCGAGTGGGTGGCCGCGGTGTCGGCGGGTGCGCCGTTGGCGGGCGGGGCGACGGGTCGAGTCGAGGAGCTGGTCGAGGGGGTGGTTGACCGCCTGGGTGGTGCGGGTGTGGCGGTGTGTTGTGCGGGTGAGGTGTTGTCGTTCGGGGAGTTGGAGGAGCGGGCGAACCGGCTGGCGTGGGGCTTGCGTGATGCGGGCGTGGGACCCGGCGACCTGGTGGGTGTGTTGTTGCCCAGGTCGGTGGACCTGGTGGTCGCTCTGTTGGGTGTGCTGAAGTCGGGTGCGGGTTATGTGCCGATGGATCCGGGATATCCGGGTGAGCGTGTCGACTTCATGGTCGAGGACTCGGGTGTCTCCCTGGTCTTGAGGTCGGTCAAGGACTTCCCGGACGGGGGCCGCACGGACCGGATAGCGGCGGCCGGGGACGGATGCGACGTGGCGTACGTGATCTACACGTCGGGATCCACCGGTCGTCCGAAGGGGGTGGTGATCGAGCACTCCCAGGTGGTGGCGATGCTGTCGTGGGCGAGCCGGGCGTTCTCGCACGAGGAGTTGGCGCAGACGCTTGCTGCGACATCGGTGTCGTTCGACCTGTCAGTGTTCGAGATCTTCGCTCCGCTGTCGGTAGGCGGGACGGTGCATCTCGTCCCCGACAACGCGCTGGACCTGATCGCGCATCCGGGCCGGTACGCGGACGTGACGCTGGTGAACACAGTTCCCTCGGTTGCTCGGGAACTGCTGGCGGCCGGTGCCATACCTCCCCGCGCCCGGACGGTGAACCTTGCCGGCGAACCTTTGGCACCACACCTGGTGGCGGAGTTGTACGCGCATCCGGTGATCGGTGTGGTCAACAACCTGTACGGGCCGAGTGAGGACACCACCTACTCGACGCACGCGGTCACCGTCGCTGGCGATGCGCGGACACCGATCGGCCGGCCCGTCGACGGTACGCGGGCTCACGTCCTGGACGGGTCTCTGCGGCCGGTAGTGGTAGGCGCGGTCGGTGAGCTGTACCTGTCGGGGGCCGGCGTCACGCGCGGCTACCACGCCCGGCCCGCGTTGACCGCGGAGCGGTACCTCCCTGATCCGTTCTCCTCGGACGGTTCCAGGATGTACCGCACGGGGGATCTCGTGCGCTGGCGTCCTGACGGACAGCTGGAGTATCTGGGCCGGGCCGACGGGCAGGTGAAGATCCGAGGCCACCGTGTCGAGCTCGGTGAGGTCGAGGAGGTCCTGCGCCGGCACCCGCACGTCTCCGAGGCGGTGGTCGTCGCCCGCCCGGACGTCACCGGGTCACTGAGGCTGGTCGGTTACGTTGTCGATCACGAGTCGGGCGGTGACGTCCCCTCCGACCTGCCCTCCCACGCACGCACCTGGCTCCCCGACTTCATGGTTCCCTCGGCCCTGGTCGGCCTCGAGGAGTTCCCTCTCCTTCCCAACGGGAAGATCGACCGCTCCGCTCTGCCCGACCCCGAGCCCGGCGCAGACCGCGCCTCCTTCTGCTCTCCGTCCGGGCCGGCCGAGGAACTGATCGCCCGCGTCTGGAGCGAACTCCTCGACGTTACTGAGATCGGCGCGGACGACGACTTCTTCGCCCTGGGCGGCCACTCCCTCCTCGCCACCCGGCTCACCCACCGGCTCGGCGAGGCCCTCGGCGCCCACATACCGCTCCACCTCGTCTTCGAACACCCCACCCTCACCGACCTCGCCGCCCATCTCCCCGATGGCACGGAGCAAGGGCGTACACCGCCGATCACCCCGCTCGACCGCGTCCCGGAACCGGACGGCACACTCGTGCTGCCGACATCGCCCGGTCAGGAACGCCTGTGGGTCCAGTGCGCGCTTGACCCGGAGGCCAACCTCGCCTACCACATCAGGGGCGCCGTCCACCTCCACGGGCCGTTGGACGAGGACGCCTTGGTCACCGCCCTCCGTCACCTAGCGCGCCGCCATGAGAGCTTGCGTACCTCGCTGCGTCAGATCGACGGCGAGCTTCGCCAGGTGGTGGCACCAGACCCCGAAGTGCCGCTGTTCCGAACCACCACCGCCGACTGGGAAGCGGTGATCGACGCCGAGACCCGGCGGCACTTCGACCTCTCCGCCGGCCCCCTCTGGCACGTCACGCTCGTCAGCGCCGGGCCCGAGCACCACGTCGTCGTCATGAGCCTGCATCACGCCATCGCCGACGGTTGGTCCATCGACATCATCCTCCGTGAGATCGCCCAGAGTTACGGCGCAGTCCTGCACGCCCCCGCCAGCGAAGCCGTCTCGCCCGCGCCCGTCCAGTACGCCGAAGCAGCAGCCTGGCAGCGCGAAACGGCGTCGGAGAACGCGGAGTTCTGGCGGTCCCACCTGGCGGGTACTACGTCGGCCGGCCTGCCGACCGACCGACCCCGTCCCCCTCGGCAGACCTACCGAGGTGACGCGGTCCCGCTGAACCTTCCTCAGAAAGCACTGGCCGGCGCGGCACGGAAGGCGGCGACCACCTCGTTCACCGTCCTCGCGACAGCCCTTGCCGTCGTCCTCGTCAAGCTCACGGACCGGTACGACGTGACCCTCGGCATTCCAGTCGCCGGCCGCGACCACCCGGACACGGCGGAGGTCGTCGGCTACCTCGTCGACACGTTGCCGCTCCATCTGCGCCCGGATCCGCAGGCCACCCTCGCCGAGACCCTGGACGCGACCCGGGCCCTCGTGGACGACGTCCGCGCCCACCCGCGCATCCCCCTCGAGGAACTGCTCCGCGAAGCACGCCCCCACGGTGACCGCGGCCCGCTGTTCCAGGTGCTGCTGGCCGTCAACGGGACGCCGCCCCGTTACGAACTGGCCGGCCTGGAGATGAGCCCGGCTCCCGTACCGTTCCGCACCACCCCTTACGACCTGGTCGTCCAGGCGGAGGAACGCGACGGCCGGGTCACCGGGCACCTGCTCTTCAACACCGACTTGTTCGAGCGCTCCACCGCACAGCTCATCGCGGACCGGCTCGCCACCGCGGTCCACGCCTTGGCCGACGGTCCCACCCTGACTGTCGCCGAGGTGGATGTGCGGTCGGTGGCGGAGCACGAGCGGGCGGTGGCGCTGTCGGCGGGTGCGCCGTTGGCGTGCGAGGCGACGGGTCGAGTCGAGGAGCTGGTCGAGGGGGTGGTTGACCGCCTGGGTGGTGCGGGTGTGGCGGTGCGGTGTGCGGGTGAGGTGTTGTCGTTCGGGGAGTTGGAGGAGCGGGCGAACCGGCTGGCCTGGGGCTTGCGTGATGCGGGCGTGGGACCCGGCGACCTGGTGGGTGTGTTGTTGCCCAGGTCGGTGGACCTGGTGGTCGCTCTGTTGGGTGTGCTGAAGTCGGGTGCGGGTTATGTGCCGATGGACCCGGGATATCCGGGTGAGCGTGTCGACTTCATGGTCGAGGACTCGGGTGTCTCCCTGGTCTTGAGGTCGGTCAAGGACTTCCCGGACGGGGGCCGCACGGACCGGATAGCGGCGGCCGGGGACGGATGCGACGTGGCGTACGTGATCTACACGTCGGGATCCACCGGTCGTCCGAAGGGGGTGGTGATCGAGCACTCCCAGGTGGTGGCGATGCTGTCGTGGGCGAGCCGGGCGTTCTCGCACGAGGAGTTGGCGCAGACGCTTGCTGCGACATCGGTGTCGTTCGACCTGTCAGTGTTCGAGATCTTCGCTCCGCTGTCGGTAGGCGGGACGGTGCATCTCGTCCCCGACAACGCGCTGGACCTGATCGCGCATCCGGGCCGGTACGCGGACGTGACGCTGGTGAACACAGTTCCCTCGGTTGCTCGGGAACTGCTGGCGGCCGGTGCCATACCTCCCCGCGCCCGGACGGTGAACCTTGCCGGCGAACCTTTGGCACCACACCTGGTGGCGGAGTTGTACGCGCATCCGGTGATCGGTGTGGTCAACAACCTGTACGGGCCGAGTGAGGACACCACCTACTCGACGCACGCGGTCACCGTCGCTGGCGATGCGCGGACACCGATCGGCCGGCCCGTCGACGGTACGCGGGCTCACGTCCTGGACGGGTCTCTGCGGCCGGTAGTGGTAGGCGCGGTCGGTGAGCTGTACCTGTCGGGAGCCGGCGTCACGCGCGGCTACCACGCCCGGCCCGCGTTGACCGCGGAGCGGTACCTCCCTGATCCGTTCTCCTCGGACGGTTCCAGGATGTACCGCACGGGGGATCTCGTGCGCTGGCGTCCTGACGGACAGCTGGAGTATCTGGGCCGGGCCGACGGGCAGGTGAAGATCCGAGGCCACCGTGTCGAACTCGGCGAGGTCGAAGAAGTCCTGCGCCGGCACCCGCACGTCTCCGAGGCGGTGGTCGTCGCCCGCCCGGACACGACCGGATCACTCCGCCTGGCCGCCTACATCGTTCCCCACGAGGCCGCCGGTGACGTCCCCTCCGACCTGCCCTCCCACGCACGCACCTGGCTCCCCGACTTCATGGTTCCCTCGGCCCTGGTCGGCCTCGAGGAGTTCCCTCTCCTTCCCAACGGGAAGATCGACCGCTCCGCTCTGCCCGACCCCGAGCCCGGCGCAGACCGCGCCTCCTTCCGCTCTCCGTCCGGGCCGGCCGAGGAACTGATCGCCCGCGTCTGGAGCGAACTCCTCGACGTTACTGAGATCGGCGCGGACGACGACTTCTTCGCCCTGGGCGGCCACTCCCTCCTCGCCACCCGGGTCGTCAGCCGCCTGACGACACTCACCGGCGCCGAGATACCCCTCCACCTCGTCTTCGAGAACTCCGTACTCGCCGACCTGGCCCGCCTGTTGCCCGATCCGGCGGGCTGGCCGGCCGGCCCCGCCCGCATCCAGCGCATCCGGCGCGTCAAGGGCGGCACGACCGCGGGGTGA	MSENHQVSADLGRDLLARWRARTPDTTAPAAPQASPIQLGLRLFEEIHPGTAANILRYDAETDGTLDTDRLATALRTLAHRHAVLRTTFPEGDRTLCAVTPEAEAVPDLTVTDLAGIGTDAGRARAHAEADARAAAPMNLATGPLWRVAVWILADGTARLQFLAHHIVADGWSLGVFLAELDALYAGRPLGPATPLPEVPATPDPAHLAAWRDRLADARPLSLPTDRPRPHTRRFRSGHVDVTVDAELMGRVQELADSNAMTPFMVLLTAFHLTLARTAGHSDITVGSPVATRERHRAPGAIGPLATMLALRTDTTGAHTVREALHAVRDTCLDAYSGAHVPIETVAEQLGRRGASLFDVLFVLQPRPGEARLGDLPVRPMVMAPVTIRNDVELYLWQGDDGVTGFLAYDTDLYSADTATLLADRFLTALSAFVECPDAVVAEVDVRSVGERERAVALSAGVPLAGGATGRVEELVEGVVDRLGGAGVAVCCAGEVLSFGQLEERANRLAWGLRDAGVGPGDLVGVLLPRSVDLVVALLGVLKSGAGYVPMDPGYPGERVDFMVEDSGVSLVLRSVEDFPDGGRTDRVPVAGDGSDVAYVIYTSGSTGRPKGVVIEHSQVVAMLSWAGRVFADGELSQTLAATSVSFDLSVFEIFAPLSVGGTVHLVPDNALDLIAHPGRYADVTLVNTVPSVVRELLAAGAIPPRARTVNLAGEPLAPGLVAELYAHPVIGVVNNLYGPSEDTTYSTHAVTVAGDARTPIGRPVDGTRAHVLDGSLRPVVVGAVGELYLSGAGVTRGYHARPALTAGRYLPDPFSAEGGRMYRTGDLVRWRPDGQLEYLGRADGQVKIRGHRVELGEVEEVLRRHPQVSEAVVVARPDVTGSLRLIGYVVAHEAGGDVPSDLPSHARTWLPDFMVPSALVGLEELPLLPNGKIDRSALPDPEPGADRASFRSPSGPAEELIARVWSELLDVTEIGADDDFFALGGHSLLATRLTHRLGEALGAHIPLHLVFEHPTLTDLAAHLDRLGKSRPPIPVTPRIPNPDGTVVFPATSGQKRLWLLCALDPQANLAYTLNGGARITGRLDAAALARAVEEVARRHEVLRTTLREENGEVVQVVHPVWSGTEADDTYASPECDEAELLSDWRHSTVDLAEGPLFRARIARRADDVHLLLLSLHHTIADGWTLTRLLDEIAAVYAALHQSHPLPPAPTLHYGDFAQMRAAELTSEDDEGLAHWRERLAGVRPLDVPTDHPRPARRTHNGAAVPVELSAEAVGDIARRTGTTPFAVVATAVTVVLGVLSGSDDVTIGIPTSGRTHPDTAGILGFFTNTLPLRRTLDPRATLAETLHATHHALVEAHEHAETPFEEIVRHTSLGADGQARSPLFQTMLALNEAPSRNLHLPGLTVSRLDIPPAGTQFDLSLHLEQGEDAISGYLTYNTDLYADSTARFFTERLASVVSVLVECPDAVVAEVDVRSVAEREWVAAVSAGAPLAGGATGRVEELVEGVVDRLGGAGVAVCCAGEVLSFGELEERANRLAWGLRDAGVGPGDLVGVLLPRSVDLVVALLGVLKSGAGYVPMDPGYPGERVDFMVEDSGVSLVLRSVKDFPDGGRTDRIAAAGDGCDVAYVIYTSGSTGRPKGVVIEHSQVVAMLSWASRAFSHEELAQTLAATSVSFDLSVFEIFAPLSVGGTVHLVPDNALDLIAHPGRYADVTLVNTVPSVARELLAAGAIPPRARTVNLAGEPLAPHLVAELYAHPVIGVVNNLYGPSEDTTYSTHAVTVAGDARTPIGRPVDGTRAHVLDGSLRPVVVGAVGELYLSGAGVTRGYHARPALTAERYLPDPFSSDGSRMYRTGDLVRWRPDGQLEYLGRADGQVKIRGHRVELGEVEEVLRRHPHVSEAVVVARPDVTGSLRLVGYVVDHESGGDVPSDLPSHARTWLPDFMVPSALVGLEEFPLLPNGKIDRSALPDPEPGADRASFCSPSGPAEELIARVWSELLDVTEIGADDDFFALGGHSLLATRLTHRLGEALGAHIPLHLVFEHPTLTDLAAHLPDGTEQGRTPPITPLDRVPEPDGTLVLPTSPGQERLWVQCALDPEANLAYHIRGAVHLHGPLDEDALVTALRHLARRHESLRTSLRQIDGELRQVVAPDPEVPLFRTTTADWEAVIDAETRRHFDLSAGPLWHVTLVSAGPEHHVVVMSLHHAIADGWSIDIILREIAQSYGAVLHAPASEAVSPAPVQYAEAAAWQRETASENAEFWRSHLAGTTSAGLPTDRPRPPRQTYRGDAVPLNLPQKALAGAARKAATTSFTVLATALAVVLVKLTDRYDVTLGIPVAGRDHPDTAEVVGYLVDTLPLHLRPDPQATLAETLDATRALVDDVRAHPRIPLEELLREARPHGDRGPLFQVLLAVNGTPPRYELAGLEMSPAPVPFRTTPYDLVVQAEERDGRVTGHLLFNTDLFERSTAQLIADRLATAVHALADGPTLTVAEVDVRSVAEHERAVALSAGAPLACEATGRVEELVEGVVDRLGGAGVAVRCAGEVLSFGELEERANRLAWGLRDAGVGPGDLVGVLLPRSVDLVVALLGVLKSGAGYVPMDPGYPGERVDFMVEDSGVSLVLRSVKDFPDGGRTDRIAAAGDGCDVAYVIYTSGSTGRPKGVVIEHSQVVAMLSWASRAFSHEELAQTLAATSVSFDLSVFEIFAPLSVGGTVHLVPDNALDLIAHPGRYADVTLVNTVPSVARELLAAGAIPPRARTVNLAGEPLAPHLVAELYAHPVIGVVNNLYGPSEDTTYSTHAVTVAGDARTPIGRPVDGTRAHVLDGSLRPVVVGAVGELYLSGAGVTRGYHARPALTAERYLPDPFSSDGSRMYRTGDLVRWRPDGQLEYLGRADGQVKIRGHRVELGEVEEVLRRHPHVSEAVVVARPDTTGSLRLAAYIVPHEAAGDVPSDLPSHARTWLPDFMVPSALVGLEEFPLLPNGKIDRSALPDPEPGADRASFRSPSGPAEELIARVWSELLDVTEIGADDDFFALGGHSLLATRVVSRLTTLTGAEIPLHLVFENSVLADLARLLPDPAGWPAGPARIQRIRRVKGGTTAG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	557.19	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1629	colistin A; colistin B
BGC0000394.1|Naphthyridinomycin_20 # 39551 # 40276 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.640	BGC0000394.1|Naphthyridinomycin_20 	39551	40276	+	Loose	575	26.5646	PLN-1	38.46	3006972	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	PLN beta-lactamase	ATGAAACAGGAAGAGAAGACGCTCGACATGCCCCCGGCGCCTGTCGCCGAGAGCGCTCACACGGCGAAGCCGCCCGCGCCCGTACCGGACCTGTCCGACGGCCCCCGAGCCAACGAGCCCGCCATGCTGGGCTTCGGAGGCTTCCTGCTGGGCTCCATCTCGCTCGCCTTCTACCTGAAGGACGTCAGCGTTCCCGCCAACTCCCTGGTGGCCTCGCTGCCCATCATGGTGTTCGCCAGCACCATCATGCTGCTGATGGCCTCGGTCTGGGCGATGCGCCTGGGCGACGGGGTGTTCGCGGCGGTGTACGGCCTCTTCGGGACGTTCTGGCTCAGCTTCTCCATCCTCAGCCTCGCCCTGAACAACAACTGGATGGGACAGTTCGAGAACATCGAACAACGCCAGGCCACCGCCAACTTCGTCCTGGTCTGGGCCATCGTGATCATCCTGCTCACGCTGACCACCCTGCGCCTGCCGAGCGTCTTCACGCTGCTCTTCGTCGTCGTGTCCGCGACGCTGCTCGTGCTGTTCGGCTCGATCGAGCAGGCCATCGACCAGACCGTCAACAACCCGTTGAAGCCCAGCGACCCCTGGCTGATCTACGTCGGTATCACGACGATGTTCCTCTTCATCGCGGTCGGCATGTACATCTTCGCGAGCTTCATGCACAGGGCGACCGGCGCCAAGAACCTTCCTCTCGGCAAGCCGCTGATCAAGAGCCGCTGA	MKQEEKTLDMPPAPVAESAHTAKPPAPVPDLSDGPRANEPAMLGFGGFLLGSISLAFYLKDVSVPANSLVASLPIMVFASTIMLLMASVWAMRLGDGVFAAVYGLFGTFWLSFSILSLALNNNWMGQFENIEQRQATANFVLVWAIVIILLTLTTLRLPSVFTLLFVVVSATLLVLFGSIEQAIDQTVNNPLKPSDPWLIYVGITTMFLFIAVGMYIFASFMHRATGAKNLPLGKPLIKSR	MLKQSINTVVLLLFLTFSSLFACAQKVAEPTRNPPEWTQPYQPFRIAGNLYYVGTSDLASYLITTPKGHILINTGLSSSLSSIKANVKTLGFKFSDIKILLTTQAHFDHMGAMAAIKKLTGAKFMVDEKDAKVAADGGRSDYALGGHRSTYVPVKADRILHDKDKITLGGMELVMLHHPGHTQGSCSFLFNVKDESRVYSVLIANMPTIVTEKKFSEVTTYPGIAKDYAYTLNAMKKLKFDMWLSSHASQFGLLTKHKPGDAYNPAAFIDQKGYDSAIRDLEDKFLRKE	83.39	gnl|BL_ORD_ID|4559|hsp_num:0	5629			513	630	
BGC0000394.1|Naphthyridinomycin_21 # 40370 # 41425 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.742	BGC0000394.1|Naphthyridinomycin_21 	40370	41425	+	Loose	500	28.1054	PER-15	39.06	3006136	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam; penem	antibiotic inactivation	PER beta-lactamase	ATGACCGACTACCTGCCCGACGTCGCCACCGTCCCCTTCCCCATGCCGCGCCCGGAAGATCTGCCGGGCGACGTCCCGGCCCTCGCGGCGGCGGCCCCCTCCGCCCTCGCCGGCCTGGCCGGCACGGTGGCCGACCCGGCGCACCGGACCGGTCTCGCCGGCATGCTCGCCGCCGTACGGACCGCTCGCGCGGATCTGGGCCCGGTGCCGAGCACCCTCGTCGTGGACGATCCGGGGGAGTCCCGGCCGAACCGCCACAACGATCTGGCGTTCGGCATAGAACGCCGCCACGGTGACCCGCTCACCCTGTTCGTCGCGGCGGCGCTCAACGCCCACCTCGGCATCCTGGAAATCGCCGAGGAACGGGGCACCGGCCTGGACGAGTCGGCGTGGCACGACCTGGTCGCGGGCTTCGACACCCTGGTGCGATGGCCGACCGATCCCACCCGGCTGCCGGCGCCGTTGCCGGTGCCCGGCTGCCCGTCGTCGGGGGAACCCGAACCCCTCGACGGGCTCCGGCGCTGGGTGCGCGGCCACCATGTCTTCATGGTGCTAGCCCAAGGCGGCACCGTCGCCGTGAAGAGTCTCACGGCGGCGGCCGAGGCCGGCGACGAGGAGGCCGCCGCCACGGCGGCCGAAGTGGCCTCCCGGGTCATGCGGGCCTGCCGGGCCGCCCTCCAGTTCGCCGGAGACGCCAACCCTGACCAGTACCGGTCGGAGATCAGGCCCACCCTCATGCCGCCGGTGGCGCCCCCGCAGATGAGCGGGTTGCGCTGGCGGGACCACGAGGCACTGGTGGCCGCGCTGACCGCGTCGGGCGAGGCCTGGTCCTGGCTGGCGGAGCGCCGCCCCGACGCCCTGACCGACTTCCGGACCGCACTCGACGCCACGTACGAGTCGCACAAGGGCGTGTGCGGGAACTTCGTCGGCAGCCAGTCACCGAGTCTTCTCGCGACCAGCAGGTCCCACCGGCCCGCGGTCGGCGTCATCGAGCAGTTCCGCCGGCTGCGGGTGGGCACCCTGCCCGCAGTCCCGCACCCCGACCACCACACATGA	MTDYLPDVATVPFPMPRPEDLPGDVPALAAAAPSALAGLAGTVADPAHRTGLAGMLAAVRTARADLGPVPSTLVVDDPGESRPNRHNDLAFGIERRHGDPLTLFVAAALNAHLGILEIAEERGTGLDESAWHDLVAGFDTLVRWPTDPTRLPAPLPVPGCPSSGEPEPLDGLRRWVRGHHVFMVLAQGGTVAVKSLTAAAEAGDEEAAATAAEVASRVMRACRAALQFAGDANPDQYRSEIRPTLMPPVAPPQMSGLRWRDHEALVAALTASGEAWSWLAERRPDALTDFRTALDATYESHKGVCGNFVGSQSPSLLATSRSHRPAVGVIEQFRRLRVGTLPAVPHPDHHT	MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEFSVPVQQLLQYSVSHSDNVACDLLFELVGAPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELKKLSALSPN	113.96	gnl|BL_ORD_ID|4548|hsp_num:0	5618			666	852	
BGC0000394.1|Naphthyridinomycin_22 # 41593 # 42657 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.684	BGC0000394.1|Naphthyridinomycin_22 	41593	42657	+	Loose	400	25.409	MexL	41.38	3003710	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCCAGACCGCATCCACCCAGCACGGCGGGCCCGCCGAGCTCGACATGGACGGCCTGTCCCGGATCCTCTTCGGGCATGCGGCCTTCCAGTACCTGAACGCGGCCTGCGAACTCGGCCTCCCGGACCTGGTGGCCGAGAAGCAGGAGCTCACCCGGGACGAGATCCGCGACGCGCTCTCCCTCCAGGACCGCGCCGTCGACATCCTCCTCCTCGGCTGCACCTCGCTCGGCATCCTCGTCAAGCAGGACGGACGGTACCGACTGGCCGGGGTCATCAAGGACCTCATGGACGAGGGCGACTGGCAGCGCTTCGTCGACACCGTGGCCTTCGAGCAGTACATCGTGTACGAGGGCCAGCTCGACTTCACCGACTCGCTCCGCGAGAACCGCAACGTCGGTCTGCGCCGGGTCCGCGGCTCCGGCCGTGACCTCTACCACCGGCTCGCCGAGAACCCGCACCTGGAGCAGGTCTTCTACCGCTACATGCGCTCCTGGTCCGAACTGGCCAACAAGCACCTGGTCCAGGAGCTCGACCTGTCCGACCGACGGCACCTGCTGGACTGCGGCGGCGGCGACGCCGTCAACGCCATCGCCCTCGCCCAGGCCAACCCGGACCTCAAGGTCACCGTCTTCGAGATCCCGGCGTCCGGCAGCATCGCCGAGAAGAAGATCGCCCAGGCCGGCGTCGGCGACCAGGTCTCCGTCATCACCGGCGACATGTTCGCCGACCCGCTGCCCACCGGCTGCGACGTGGTGATGTTCGCCCACCAGCTGGTCATCTGGACGCCGGAGGAGAACACCGAACTGCTGCGCCGCGCCTACGACGTCCTTCCCGAAGGCGGTCAACTGGTCATCTTCAACTCCATGTCCAACGACGAGGGGGACGGCCCCGTCGTCGCCGCCCTCGACAGCGTCTACTTCGCCGCGCTGCCCGCCGAGGGCGGCATGATTTACTCCTGGGCGACACACGAGCGGTGCCTGCGCGACGCCGGGTTCAGCACCGTCAAGCGCATCCCCTTCCCCGGCTGGACCCCGCACGGCGTCATCGTCGCCACCAAGTAG	MTQTASTQHGGPAELDMDGLSRILFGHAAFQYLNAACELGLPDLVAEKQELTRDEIRDALSLQDRAVDILLLGCTSLGILVKQDGRYRLAGVIKDLMDEGDWQRFVDTVAFEQYIVYEGQLDFTDSLRENRNVGLRRVRGSGRDLYHRLAENPHLEQVFYRYMRSWSELANKHLVQELDLSDRRHLLDCGGGDAVNAIALAQANPDLKVTVFEIPASGSIAEKKIAQAGVGDQVSVITGDMFADPLPTGCDVVMFAHQLVIWTPEENTELLRRAYDVLPEGGQLVIFNSMSNDEGDGPVVAALDSVYFAALPAEGGMIYSWATHERCLRDAGFSTVKRIPFPGWTPHGVIVATK	MSESTSSVGPGRPKDPAKREAILEAAKRLFLCNGYDGSSMEAIASEAGVSKLTVYSHFTDKETLFSEAVKAKCAEQLPALYFQLAEGAPLEKVLLNIARGFHRLINSHEAIALTRLMAAQAGQNPKLSELFFEAGPKQVIDEMERLLEQARRSGKLAFPDARHAAEHFFMLVKGCANYRLLIGCAEPLDEAEGERHVEEVVALFLRAFAAGG	166.98	gnl|BL_ORD_ID|4690|hsp_num:0	2219			237	324	erythromycin; tetracycline; triclosan
BGC0000394.1|Naphthyridinomycin_24 # 42853 # 43863 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=13bp;gc_cont=0.716	BGC0000394.1|Naphthyridinomycin_24 	42853	43863	+	Loose	400	33.8834	ErmG	30.43	3000522	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCGCATGCTGCTGTACGGCCAGCTCGTCTCCAAGGCGGTGTGCACAGCGGTGGAGCTCGGTCTGCCGGAGGCACTGGCGGGCGGGCGCCGCTCCGCCGAGGACCTCGCCGGCGACGTGGACGCCCACCCCCTCGCCCTGCGCCGGCTGCTCCGCGCACTCGTCCCCTTCGACGTGTTCACCGAGGAGCCCGACGGTACCTTCGCGCTGACCCGCCTCGGTGCCACCCTGCTGCCTGACACCCCCGGCACGGCACGTCCCAGCGCCCTGCTGCTCGCCGGTGAAGTCGGCCGCACCTGGCAGGAGTTCGGGCACTCCGTGCGGACCGGCGACTCGGCGTTCACCCTGCTTCACGACTGCGCCCTCTTCGAGCACCTGGAGCGGCGGCCGGAGCGGCGCGAAGTCTTCGACCGGTCCCAGGAGGCCGGACTGCGACTGGAGCTGGACGAGATCTTCGACGCGGTCTCCTTCGACCGGTACCCCACGATCGTGGACGTCGGGGGCGGCAACGGCCACCTGATGTGCGAACTGCTGCACCGCACCCCGGGCAGCACCGGCAGCGTCATCGATCTGCCCGGCACCGTGCAGCTCGCCGAGAAGCGCATCGTGGAAGGAGGGCTCACCGACCGTTGCACCGCCGTCGTCGGCGACTTCTTCGACAGCGTCACACCCGGCGCGGACCTCTACATCCTCAGCCACATCCTGCACGACTGGGGTGACGACAGCGCTGTCTCCATCCTGCGTACCTGCGCCGCCGCCATGCCCGCGCACGGTCGCCTCATGGTGATCGACCTGCTCACCGACGCCGCCGCGGACGACCGGGGCGGACGCCACCGGCTCCCCGCCCTCATGGACCTCTACATGCTCTCCCTCTTCGGAGCGGCGGGCGGCCAGGAGCGCACCGGCGCGGAGTTCACCGCGCTGCTCACGGCCGCCGGACTGGAACCGGAGGAGACCAGGGTGCTGCCCAGCGGCATGGGCGTCATCACGGCCCGGCGGCGCAGCACCTGA	MRMLLYGQLVSKAVCTAVELGLPEALAGGRRSAEDLAGDVDAHPLALRRLLRALVPFDVFTEEPDGTFALTRLGATLLPDTPGTARPSALLLAGEVGRTWQEFGHSVRTGDSAFTLLHDCALFEHLERRPERREVFDRSQEAGLRLELDEIFDAVSFDRYPTIVDVGGGNGHLMCELLHRTPGSTGSVIDLPGTVQLAEKRIVEGGLTDRCTAVVGDFFDSVTPGADLYILSHILHDWGDDSAVSILRTCAAAMPAHGRLMVIDLLTDAAADDRGGRHRLPALMDLYMLSLFGAAGGQERTGAEFTALLTAAGLEPEETRVLPSGMGVITARRRST	MNKVNIKDSQNFITSKYHIEKIMNCISLDEKDNIFEIGAGKGHFTAELVKRCNFVTAIEIDSKLCEVTRNKLLNYPNYQIVNDDILKFTFPSHNPYKIFGSIPYNISTNIIRKIVFESSATISYLIVEYGFAKMLLDTNRSLALLLMAEVDISILAKIPRYYFHPKPKVDSTLIVLKRKPAKMAFKERKKYETFVMKWVNKEYEKLFTKNQFNKALKHARIYDINNISFEQFVSLFNSYKIFNG	137.70	gnl|BL_ORD_ID|915|hsp_num:0	989			45	183	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000394.1|Naphthyridinomycin_25 # 44009 # 45598 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=13bp;gc_cont=0.696	BGC0000394.1|Naphthyridinomycin_25 	44009	45598	+	Loose	900	364.385	QepA4	49.41	3004379	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACTCACGACCCGACCGCTTCCCCGCCCGCCCGTGCCGGGAAACGCGAATGGACAGCTCTGGGTGTCCTCGCCTTACCGGCGTTGCTCATCAGCCTCGACACCACGGTGCTGCACCTGGCGGTCCCGCATCTCAGCGGGAGCATCGACCCCAGCGGCCTGCAGCTGCTGTGGATCGTCGACATCTACAGCTTCCTGATCGCCGGTCTGCTCATCATCGCGGGCACGCTCGGTGACCGGTTCGGCCGGCGTCGGCTGCTGGTGGCCGGGGCGGCGGGCTTCGGGCTGGCCTCCGTACTCACGGCGTTCTCGACCAGCGCGGAGATGCTGATCGTCAGCCGGGCGCTGCTGGGCATCGCGGGAGCGACCCTGATGCCCTCCTCGATGTCCCTGATCCGCAACATGTTCCTGGACGCACGACAGCGTTCCGTCGCCTTCAGCGTGTGGATCGCCTGCTTCCTGGTGGGAGGAGCGCTCGGCCCCCTCGTCGGCGGAGCGATGCTGGAACACTTCTGGTGGGGATCGGTCTTCCTGCTGAGCGTGCCCGCGATGGTGCTGCTGCTGATCCTGGGGCCGGTACTGCTCCCCGAGTACCGCGACCCGAACCCCGGCAGGATCGACCCCGCGAGCGTGCTGCTGCTGGTGGCACCCCTGCTGACGACGGTGTACGGGCTCAAGGTGCTCACCGGTGAGGGCTTCGGCGTCCTGCCGGTGACGTTGCTCCTCGCCGGGCTCGCACTGGCCGTGCTCTTCGCCGTCCGCCAACGGCGCCTCACCCACCCCCTGCTGGACCCCGCCCTGTTCCGTGAGCGCACCTTCACCGTCTCCCTCGTCACCATGGGCGTCGCGCTCTTCGTCATGTCGGGATCACAGTTCTTCGTCGCGCAGTACCTCCAGATGGTGGTGGGACTGTCGCCCTTGGAGACGGGGCTGGCGTCGCTGCCCGGCAGTGTCGGCGGGGTGATGGGTGCCCTGCTGGCCCCGGTGGCACTGCGCTGGATGCGGTCCGCGTACGTGATGACAGCCGGGCTCACCATGGCCGTGATCGGTTTCGCCGTACTGACCCAGGTCGAGACGGAGGGGGGTCTCGTCCCGGTGATGATCGCGGTAGGGATGCTCAACTTCGGCGTCGCGCCGACCATCGCGCTCGGCACCGACATGATGATCGCGTCCGCGCCGCCCGAGAAGGCCGGAGCGGTCTCCGCGATCTCCGAGACCTGCCAGGAACTGGGGCTGGGCATGGGCGTCGCGATCCTCGGCAGCGTCGGGACCGCGGTGTACCGCGCCGAGGTCGCGGACACCCTGCCCGCCGGCGTGGCCTCCCGCGCCCAGGACACCATCGGTTCGGCCGTGGACGAGGCCGGGAGGCTGCCGGACGAGCTCGGCACGACGGTCCTCACCGCGGCCCGGGAGGCGTTCACCGACAGCCTCTTCCACGTCAGCGTCATCTGCACGGTGGTGACCCTGCTGATCGTGGTCACCATCGCGGTGCTGCGCCCGACTCCGGAGGGCGACGGTCACGCCCTGGACGACGCCGACGGGTTGAACGGTCCCGGGGGCACCGAGGTGCCGTCGCGCACGAACTCCTGA	MTHDPTASPPARAGKREWTALGVLALPALLISLDTTVLHLAVPHLSGSIDPSGLQLLWIVDIYSFLIAGLLIIAGTLGDRFGRRRLLVAGAAGFGLASVLTAFSTSAEMLIVSRALLGIAGATLMPSSMSLIRNMFLDARQRSVAFSVWIACFLVGGALGPLVGGAMLEHFWWGSVFLLSVPAMVLLLILGPVLLPEYRDPNPGRIDPASVLLLVAPLLTTVYGLKVLTGEGFGVLPVTLLLAGLALAVLFAVRQRRLTHPLLDPALFRERTFTVSLVTMGVALFVMSGSQFFVAQYLQMVVGLSPLETGLASLPGSVGGVMGALLAPVALRWMRSAYVMTAGLTMAVIGFAVLTQVETEGGLVPVMIAVGMLNFGVAPTIALGTDMMIASAPPEKAGAVSAISETCQELGLGMGVAILGSVGTAVYRAEVADTLPAGVASRAQDTIGSAVDEAGRLPDELGTTVLTAAREAFTDSLFHVSVICTVVTLLIVVTIAVLRPTPEGDGHALDDADGLNGPGGTEVPSRTNS	MSATLHDTAADRRKATRREWIGLAVVALPCLVYAMDLTVLNLALPVLSRELQPSSAQLLWILDIYGFFVAGFLITMGTLGDRIGRRRLLLIGAALFAFASVLAALADTAALLIAARALLGLAGATIAPSTMALIRNMFHDPRQRQFAIGVWIAAFSLGSAIGPLVGGVLLEFFHWGAVFWLNVPVMLLTLALGPRFLPEYRDPDAGHLDLASVLLSLAAVLLTIYGLKQLAEHGAGLASMAALLAGLAVGALFLRRQGHIAYPLLDLRLFAHAPFRAALAAYALAALAMFGVYIFMTQYLQLVLGLSPLQAGLATLPWSLCFVIGSLLSPQLAARWPAARILVVGLSAAAFGFAVLGLGQGLWWLVPATIVMGLGLAPVFTIGNEIIITSAPSERAGAASALSETVSEFSGALGIALFGSVGLVVYRQALTSAALPGLPADALQAAGASLGGAVHLADTLPAWQGAALLAAARAGFTDALQATAWAGAVLVLVAAGLVARLLRKRPALASG	103.52	gnl|BL_ORD_ID|2490|hsp_num:0	2880			15	1518	
BGC0000394.1|Naphthyridinomycin_26 # 45924 # 47546 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.698	BGC0000394.1|Naphthyridinomycin_26 	45924	47546	+	Loose	375	26.1794	ALI-2	33.33	3006895	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ALI beta-lactamase	ATGTCTGAACTGAACCGCCGGGGATTACTCACGCGCGCCGGACTGGTCGGGGCCGGCCTGGTCTCGGCGGACTTCTTAGCAGGCGGCGGCACCGCGGCCGCGGCCGGGAAGAACACCGCGAAGAGCGCGGGAAAGTGCGCCCCGGCGTTCGACACCGTCACCGTGCAGCCCGGGGATCCCCGGTACGACAGCTTCATCCGCGCGCACAACACCCGCTTCAGCAACCGGCCGGATCAGGTCACCATCGCGACCTCCTCGGACCAGGTCGCCGAGGCGCTCGGCCGCGCCGTCGCGGCCGGCCAGGAGGTCGCCGTCCGTTCCGGCGGTCACTGCCTCGAGAACTTCACGACGTACTCCGGGGTCAAGCACCTCATCGACCTCTCGCAGATGCAGGACGTCTACTACGACGAACGCCGGGGTGCCTTCGCCGTGGGTCCCGGCGCGATCGTGGCCCCCACGCAGAACACGCTCTTCAAGGGCTGGGGCGTGACGATACCCTCGGCGGGCTGCTCGGAAGTGGGCCTCGGCGGGCACATACTCGGCGGCGGCTACAACTTCTACTCCCGCATCCACGGCATAGCCGTCGACCACCTCGACGCCGTCGAGGTGGTCGTGGTCGGTGCCGACGGGCAGCCCCGCACCATCGTGGCGACCCGTCGCCAGGACGACCCCAACCGCGCCCTGTGGTGGGCGCACACGGGCGGCGGCGGCGGCAACTTCGGGATCGTCACGCGGTACTGGCTGCGCACGCCCGGAGTGAACTCCAGCGACCCCGCCAAGCTGCTGCCCCGCGGCTCGAACCAGCGGGTCCGCAACGTGCAGTGGTCGTGGAACGATCTGTCGCCGCAGGCGTTCAGGACGCTCGTGCGCAACTTCTCCCGGTGGTACGAGCTCAACAGTGCCCCGGGGGCCAGGGAGGTCCAGGTGTGGGCCTCGTTCTCCGCCTCCCACCAGGCCGCCGGCGTGATCGGTCTGATGGCCGGTGTCTCCAAGGACGTTCCGGGCGGCGAGGCCCTGCTCGACGCGCTCTTCGAGGCGACTGCCGCCGGAGCCGGCGTCTCTCCCGTGGCCGACTCGCGGTCCGAACTGCCGTGGCTCGACCGCGACAACTGGTACTGGGGTCCCCCCGGACGCCAGAAGGACAAGACGGCGGACCTCAAGAAGAGCTACACCGACGAGCAGCTGGACACGATCTACGCCTACCTGACCGACGACCACGGCGATCCCGGCGCACAGGTGAATCTGGCCGCCCTCGGCGGCAGGATCAACTCGGTACGTTCCGACGCGACCGCCTACGTCCACCGGGACTCGATCCTGCGCGTCTACTTCACGCCCGGCGTGTGGCGCGCGGAGGCTCAGGACGCCAAGTACGTCGCGTGGGTGCGGAAGCTGTACCGAGACGTCTACCGCAACACCGGCGGTGTCCCGGCGCCCGACGCCGCCAACTCGGGGGCGTACATCAACTACCCGGACGTCGACCTCGCCGACCCGGAGTGGAACACCTCCGACACCCCCTGGCACGGCCTGTACTACGGAGCGAACTACGCGCGGCTCCAGCGGGTCAAGTCCGCCTACGACCCGCGTGACGTGTTCCACCACGCGCTGTCGATCCGGCCCGCCTGA	MSELNRRGLLTRAGLVGAGLVSADFLAGGGTAAAAGKNTAKSAGKCAPAFDTVTVQPGDPRYDSFIRAHNTRFSNRPDQVTIATSSDQVAEALGRAVAAGQEVAVRSGGHCLENFTTYSGVKHLIDLSQMQDVYYDERRGAFAVGPGAIVAPTQNTLFKGWGVTIPSAGCSEVGLGGHILGGGYNFYSRIHGIAVDHLDAVEVVVVGADGQPRTIVATRRQDDPNRALWWAHTGGGGGNFGIVTRYWLRTPGVNSSDPAKLLPRGSNQRVRNVQWSWNDLSPQAFRTLVRNFSRWYELNSAPGAREVQVWASFSASHQAAGVIGLMAGVSKDVPGGEALLDALFEATAAGAGVSPVADSRSELPWLDRDNWYWGPPGRQKDKTADLKKSYTDEQLDTIYAYLTDDHGDPGAQVNLAALGGRINSVRSDATAYVHRDSILRVYFTPGVWRAEAQDAKYVAWVRKLYRDVYRNTGGVPAPDAANSGAYINYPDVDLADPEWNTSDTPWHGLYYGANYARLQRVKSAYDPRDVFHHALSIRPA	MFKFITGIVVAFVSFNTLSAPMLKPLQFEEVTTNIFLVKSFREFKNLKSPDNPIIIDANSLIYIDSKDAYLIDTPWNAENMPQLMTWIENRDLTLKKTVFTHFHEDQTGGLEYLQEHGFDTYATKLTNTLLVKDNKKAANHELDAQESVLLDNKIEVFYPGPGHSKDNSVVWFPKEKVLLGGCLMRANEVNTIGWTGDADLAKWAQSAKNVLIKYPETKLVIPGHGDIGKGTSVISHTVNIAESL	220.41	gnl|BL_ORD_ID|3292|hsp_num:0	4361			120	246	
BGC0000394.1|Naphthyridinomycin_27 # 47660 # 48733 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.689	BGC0000394.1|Naphthyridinomycin_27 	47660	48733	+	Loose	500	29.261	OXA-258	37.04	3001503	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGGCGACCTTTCTCATTTCCGCCGCCGGACCATGCGACGCGCCTTTCCGGTCGGCCGCGAGTTCACGCGGAACGAGTCGGTCCGGCCGCGCGTCCAAGCGTCACAGAAAGCTGACGAATATCCCCGGAAGCTCCCCGTGCCGTACTTCCGCCGAACCTTGCGGCCGCGGCGGCAATCCCGGCCCGAGTGCCCGGGGCCGAACCAGAGCAGAGACGACAGGAAGACAGATATGGCTGCCGAGATATCCGGCGTCGGCGACGTCGCGAGTTTCTACGAGGGCCTCGGCCAGGTTCTCAATATCGCCTGGGGCGAGAATCTGCACTACGGCTACTGGGAGGACGACGCCGACGACAGCACGGTCGAGGTCGCCACGGCCCGGCTCACGGACCTGCTGATCAGTCTGCTCGACCCCGCGCCCGGCGCCGGTGTCCTCGACATCGGCTGCGGTGTCGGCAAGCCCGCTCTCCAGCTCGTCGCGGCCAGGAAAGCGCGTGTCACCGGCATCTCGATCAGCGACGTCGAGGTGAAGCAGGCCACGCAGCGCGCCGCCGAGGCGGGCCGTTCGGACCTGGCCGCCTTCCGCAACGCGGACGTACAGGACCTGCCTTTCGACGACAACTCGTTCGACGGAGCCTGGGCGGTGGAGTCCCTGCTCCATGTGCCGGACCGGGGCCGCGCGCTCGCCGAGACGGCCAGGGTGCTGCGCCCCGGCGGACGACTGGTGATCGCCGACACCGTCCAGCGCCCGCCGCTGGACGCCGAGGCCCGCGCCGTTCTCGACGAGTTCAGGACCTCCTACCACGTGAGCGCCTACGCCACCGCCGATGAATACCGGGGACTGCTCACCGCGAACGGATTCGTCGACATCGACATCCGTGACATCAGCGACAAGGTGGTCCGGACCGGAATGATCATGGCTGACGCCGTCGAGGCCCGACGCGACGAACTGGCCCGCATCGACGGGCCGGAACCGGTCGACCAGTACATCGGCCTCATGCGCCGCGCGGCGGCCAGCCCGGGCATCGGATACCTGGTGATCGCAGCGACGCGGGACCCGGCATCCACCTCCTGA	MGDLSHFRRRTMRRAFPVGREFTRNESVRPRVQASQKADEYPRKLPVPYFRRTLRPRRQSRPECPGPNQSRDDRKTDMAAEISGVGDVASFYEGLGQVLNIAWGENLHYGYWEDDADDSTVEVATARLTDLLISLLDPAPGAGVLDIGCGVGKPALQLVAARKARVTGISISDVEVKQATQRAAEAGRSDLAAFRNADVQDLPFDDNSFDGAWAVESLLHVPDRGRALAETARVLRPGGRLVIADTVQRPPLDAEARAVLDEFRTSYHVSAYATADEYRGLLTANGFVDIDIRDISDKVVRTGMIMADAVEARRDELARIDGPEPVDQYIGLMRRAAASPGIGYLVIAATRDPASTS	MTVRLVSRALGAVLFASALTLPARADVLCTLVADAADGRILFQQGTRQDCTQRYTPASTFKLPIALMGADAGILQGPHQPVWNYQPAYPDWGGEAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPFEQVDFLRKFVNRQLPVKAAAYDLAENLFEVGEADGWRLYGKTGTGSPGSHGVYTPANAYGWFVGWARKDDRQLVFARLLQDEGATQPNAGLRARDGLMRDWAAMVAAPRK	130.29	gnl|BL_ORD_ID|1531|hsp_num:0	1659			315	477	cloxacillin; oxacillin; cefalotin
BGC0000394.1|Naphthyridinomycin_28 # 48891 # 49826 # -1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.690	BGC0000394.1|Naphthyridinomycin_28 	48891	49826	-	Loose	900	28.4906	tet(O/32/O)	29.85	3007119	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGGAACGCACGCCCGACACGCCGGCTCCGGACCTTCGGGGGAAGATCGCGCTGGTCGCGGGTGCCACGCGGGGAGCCGGACGAGCCATCGCCGTCCAGCTGGGCGCGGCGGGTGCGACGGTCTACGTCACCGGCCGTACGACGCGGGAACGTCGCTCGGAGTACAACCGGTCCGAGACGATCGAGGAGACCGCGGAGCTGGTCACGGAGGCGGGCGGAACCGGGATCGCGGTGCCGACCGACCACTTGGTGCCCGAGCAGGTCCGCGCGCTCGCCGACCGCGTCGACACCGAGCAGGGGCGGCTCGACGTACTGGTCAACGACGTCTGGGGAGGTGAGCGACTGTTCGAGTTCGACAAGAAGGTGTGGGAGCACGACCTCGACGCGGGGCTGCGGCTGATGCGGCTCGGTGTGGACACCCATGCGATCTCCAGCCACTTCCTCCTGCCTCTGCTGGTGCGTCGGCCCGGCGGACTCGTGGTGGAGATGACCGATGGGACGGCCGCGTACAACGGCAGCCACTACCGCAACTCGTACTTCTACGACCTGGTCAAGAACAGCGTGCTGCGCATGGGGTACGTGCTGGCCCACGAGCTGGAGCCGTACGGCGGCACGGCGGTGACGCTCACGCCGGGCTGGATGCGTTCGGAGATGATGCTCGAGACGCTCGGTGTCACGGAGGAGAACTGGCGCGACGCGCTGACCGAGGTGCCGCACTTCTGCATCTCGGAAAGCCCCTCGTACGTGGGACGCGCGGTCGCGGCGCTGGCGGGTGACGCGGATGTCGCGCGCTGGAACGGCCAGTCGGTTTCCAGTGGGCAGCTCGCTCAGGAGTACGGCTTCACCGACCTCGACGGCTCGCGTCCCGACTGCTGGCGCTATCTGGTGGAGGTGCAGGAGGCGGGGAAGCCTGCCGACCCGTCCGGGTATCGGTGA	MERTPDTPAPDLRGKIALVAGATRGAGRAIAVQLGAAGATVYVTGRTTRERRSEYNRSETIEETAELVTEAGGTGIAVPTDHLVPEQVRALADRVDTEQGRLDVLVNDVWGGERLFEFDKKVWEHDLDAGLRLMRLGVDTHAISSHFLLPLLVRRPGGLVVEMTDGTAAYNGSHYRNSYFYDLVKNSVLRMGYVLAHELEPYGGTAVTLTPGWMRSEMMLETLGVTEENWRDALTEVPHFCISESPSYVGRAVAALAGDADVARWNGQSVSSGQLAQEYGFTDLDGSRPDCWRYLVEVQEAGKPADPSGYR	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMNIPTIIFINKIDQNGIDLQRVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIISGSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAITETFITETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNGEIVPVDHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREALLNALTEIADTDPLLHFDIDTVTHEIILSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIYLERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	48.67	gnl|BL_ORD_ID|4793|hsp_num:0	5789			891	1053	tetracycline
BGC0000394.1|Naphthyridinomycin_29 # 50332 # 51018 # -1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.700	BGC0000394.1|Naphthyridinomycin_29 	50332	51018	-	Loose	600	28.4906	APH(7'')-Ia	40.0	3002661	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(7'')	ATGAGCCTGCGGCGTATCCTGCCCCAAGTGATCGAGCAACTGCTGCCTTCGGCCGTCGTATCGGTGGAGGCCTACGGCCAGAACGACGCGGACCTCACGCTCTTCCCCGAGGAAGCGGCGTTCATGACGCGGGCGGTCGCCAAACGGCGGCGGGAGTTCACCGTCGTGCGTTCCTGCGCCCGGCGCGCCATGGAGAAGCTCGGTGTGCCGCCGCAGCCGATCCTCCCGGGGGAGCATGGCGCTCCACGCTGGCCGGCCGGGCTGGTCGGCAGCATGACCCACTGTGACGACTACTGCGCCGCCGCGCTTGTCCGCACAGCGGATCTGGCCTCGCTCGGCATAGACGCCGAGGTGCACCAGCCGCTCCCCGACGGGGTACTGCCGGCGGTGTCCCTGCCGGCCGAGGCGGACCGGCTGCGGCGTCTCTCCGACCGGCGCCCCGACGTGCACTGGGACCGGCTGCTCTTCAGCGCCAAGGAGTCCATCTACAAGACGTGGTTCCCCCTCACCCGGAAGTGGCTTGACTTCACGGAGGCCGACATCGAGTTCTCCGAGGACGGCCACTTTCGCGCGACGCTCCTCGTCCCCGGTCCCCGGGTGGGCGGCCACCACCTCGACCACTTCGAAGGCCGATGGACGACGGACCATGGCCTGATCGCCACGGCCGTGGCGGTCCCGCACACCTGA	MSLRRILPQVIEQLLPSAVVSVEAYGQNDADLTLFPEEAAFMTRAVAKRRREFTVVRSCARRAMEKLGVPPQPILPGEHGAPRWPAGLVGSMTHCDDYCAAALVRTADLASLGIDAEVHQPLPDGVLPAVSLPAEADRLRRLSDRRPDVHWDRLLFSAKESIYKTWFPLTRKWLDFTEADIEFSEDGHFRATLLVPGPRVGGHHLDHFEGRWTTDHGLIATAVAVPHT	MTQESLLLLDRIDSDDSYASLRNDQEFWEPLARRALEELGLPVPPVLRVPGESTNPVLVGEPDPVIKLFGEHWCGPESLASESEAYAVLADAPVPVPRLLGRGELRPGTGAWPWPYLVMSRMTGTTWRSAMDGTTDRNALLALARELGRVLGRLHRVPLTGNTVLTPHSEVFPELLRERRAATVEDHRGWGYLSPRLLDRLEDWLPDVDTLLAGREPRFVHGDLHGTNIFVDLAATEVTGIVDFTDVYAGDSRYSLVQLHLNAFRGDREILAALLDGAQWKRTEDFARELLAFTFLHDFEVFEETPLDLSGFTDPEELAQFLWGPPDTAPGA	68.67	gnl|BL_ORD_ID|651|hsp_num:0	706			48	168	hygromycin B
BGC0000394.1|Naphthyridinomycin_30 # 51312 # 51977 # -1 # ID=1_30;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.739	BGC0000394.1|Naphthyridinomycin_30 	51312	51977	-	Loose	200	38.5058	Pseudomonas aeruginosa soxR	33.33	3004107	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGCATCTCCGAGCTGAGCCGCCGCAGCGGGGTCTCCATCCCCACGATCAAGTACTACCTGCGGGACGGACTACTGCCCGCGGGCCGCCCCACCGCCGCCAACCAGGCCGAGTACGACGAGGAACACGTGCGCCGGCTGCGGCTGATCCGTTCCCTGATCGGGGTCCGCGGGCTGTCCGTGAGCGCCACCAGGGACGTCCTGGCCGCGGTGGACGAACAGCAGGGCGACGTGCACCTGCTGCTCGGGCTGGTGCTCGGCGCGCTGCCCGTGGAGCGGTCCGGCAGACCGCCGCGCCGGGACGGCGACGCGGAACCGGACGGCGCGGGGGCCACCGCCGGTGACATGGCCGAGGACGTGGCCGCGCTGACCGCCGAGATGGGCTGGAGGACGTCCCCGAACCCGCCCGCCGCGCAGGTGGTCACCGAGACGCTGGAGACGATGCGGGCGCTCGGGATGGACTACGACTGGCGCTCCCTCGTCCCCTACGCCGAACTCGCCGACCGGGCGGCGAGGCTCGACCTCGACCAGCTGCGGGACGCGGGCGACCCGCTGCAGCAGGCCGAACGGGCCGTCCTGCTGACCGTGCTGCTGGAGCCCGCGCTGTTGGCCCTGCGGCGGCTCGCGCAGGAGCACCACTCGGCGCTGCGCTTCGGCAACGGCTGA	MRISELSRRSGVSIPTIKYYLRDGLLPAGRPTAANQAEYDEEHVRRLRLIRSLIGVRGLSVSATRDVLAAVDEQQGDVHLLLGLVLGALPVERSGRPPRRDGDAEPDGAGATAGDMAEDVAALTAEMGWRTSPNPPAAQVVTETLETMRALGMDYDWRSLVPYAELADRAARLDLDQLRDAGDPLQQAERAVLLTVLLEPALLALRRLAQEHHSALRFGNG	MKNSCASRELSVGELARRAGVAVSALHFYETKGLISSQRNAGNQRRFSRETLRRVVVIKVAQRVGIPLAEIARALQTLPAGRSPSAADWARLSAQWKEDLTERIDKLLLLRDQLDGCIGCGCLSLQACPLRNPGDQLSAEGPGAHWLDAEGREHDG	141.67	gnl|BL_ORD_ID|2395|hsp_num:0	2775			27	177	tigecycline; ciprofloxacin; acriflavine; tetracycline; rifampin; chloramphenicol; ampicillin; norfloxacin; cefalotin; triclosan
